Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	DENND4A IQSEC2 RALGAPB RGS12 ARHGAP6 DENND1B SIPA1L1 AGFG1 DEPDC5 HERC1 SIPA1L2 DNMBP TNS3	3.57e-06	507	108	13	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	DENND4A IQSEC2 RALGAPB RGS12 ARHGAP6 DENND1B SIPA1L1 AGFG1 DEPDC5 HERC1 SIPA1L2 DNMBP TNS3	3.57e-06	507	108	13	GO:0030695
GeneOntologyBiologicalProcess	regulation of cellular component biogenesis	ATMIN DCDC2 PODXL SYNE1 IQSEC2 APC MARCHF7 TSC1 SLITRK1 PIKFYVE CDKL5 ARHGAP6 SLITRK2 ALMS1 SIPA1L1 MARK4 NAV3 CAMSAP2 DCLK1	1.39e-05	1189	109	19	GO:0044087
GeneOntologyBiologicalProcess	regulation of organelle assembly	ATMIN DCDC2 SYNE1 MARCHF7 PIKFYVE CDKL5 ALMS1 SIPA1L1 MARK4	1.80e-05	280	109	9	GO:1902115
GeneOntologyBiologicalProcess	regulation of cilium assembly	ATMIN DCDC2 SYNE1 MARCHF7 CDKL5 MARK4	2.34e-05	108	109	6	GO:1902017
GeneOntologyBiologicalProcess	regulation of plasma membrane bounded cell projection organization	ATMIN DIP2B DCDC2 PODXL SYNE1 APC MARCHF7 TSC1 DCC PICALM SLITRK1 CDKL5 SIPA1L1 MARK4 CAMSAP2	3.85e-05	846	109	15	GO:0120035
GeneOntologyBiologicalProcess	regulation of cell projection organization	ATMIN DIP2B DCDC2 PODXL SYNE1 APC MARCHF7 TSC1 DCC PICALM SLITRK1 CDKL5 SIPA1L1 MARK4 CAMSAP2	4.83e-05	863	109	15	GO:0031344
GeneOntologyBiologicalProcess	regulation of plasma membrane bounded cell projection assembly	ATMIN DCDC2 PODXL SYNE1 APC MARCHF7 CDKL5 MARK4	5.21e-05	248	109	8	GO:0120032
GeneOntologyBiologicalProcess	regulation of cell projection assembly	ATMIN DCDC2 PODXL SYNE1 APC MARCHF7 CDKL5 MARK4	5.67e-05	251	109	8	GO:0060491
GeneOntologyBiologicalProcess	regulation of small GTPase mediated signal transduction	DENND4A IQSEC2 RALGAPB PICALM ARHGAP6 SIPA1L1 SIPA1L2 DNMBP TNS3	6.92e-05	333	109	9	GO:0051056
GeneOntologyBiologicalProcess	dendrite development	DCDC2 SYNE1 DCC PICALM CDKL5 CELSR2 SIPA1L1 CAMSAP2 DCLK1	7.25e-05	335	109	9	GO:0016358
GeneOntologyBiologicalProcess	dendrite morphogenesis	DCDC2 SYNE1 PICALM CDKL5 CELSR2 SIPA1L1 DCLK1	8.81e-05	198	109	7	GO:0048813
GeneOntologyBiologicalProcess	cilium assembly	ATMIN DCDC2 SYNE1 MARCHF7 CDKL5 NPHP3 ALMS1 CELSR2 MARK4 DNMBP	1.23e-04	444	109	10	GO:0060271
GeneOntologyBiologicalProcess	presynaptic signal transduction	BSN SIPA1L2	1.65e-04	4	109	2	GO:0098928
GeneOntologyBiologicalProcess	cilium organization	ATMIN DCDC2 SYNE1 MARCHF7 CDKL5 NPHP3 ALMS1 CELSR2 MARK4 DNMBP	2.16e-04	476	109	10	GO:0044782
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection assembly	ATMIN DCDC2 PODXL SYNE1 APC MARCHF7 CDKL5 NPHP3 ALMS1 CELSR2 MARK4 DNMBP	2.21e-04	670	109	12	GO:0120031
GeneOntologyBiologicalProcess	regulation of cell junction assembly	PODXL IQSEC2 TSC1 SLITRK1 ARHGAP6 SLITRK2 SIPA1L1 DCLK1	2.38e-04	309	109	8	GO:1901888
GeneOntologyBiologicalProcess	cell projection assembly	ATMIN DCDC2 PODXL SYNE1 APC MARCHF7 CDKL5 NPHP3 ALMS1 CELSR2 MARK4 DNMBP	2.70e-04	685	109	12	GO:0030031
GeneOntologyCellularComponent	postsynaptic density	IQSEC2 TSC1 DCC GRM5 PICALM SLITRK1 CDKL5 NETO1 SIPA1L1 BSN DCLK1	2.20e-05	451	108	11	GO:0014069
GeneOntologyCellularComponent	asymmetric synapse	IQSEC2 TSC1 DCC GRM5 PICALM SLITRK1 CDKL5 NETO1 SIPA1L1 BSN DCLK1	3.67e-05	477	108	11	GO:0032279
GeneOntologyCellularComponent	postsynaptic specialization	IQSEC2 TSC1 DCC GRM5 PICALM SLITRK1 CDKL5 NETO1 SIPA1L1 BSN DCLK1	5.92e-05	503	108	11	GO:0099572
GeneOntologyCellularComponent	neuron to neuron synapse	IQSEC2 TSC1 DCC GRM5 PICALM SLITRK1 CDKL5 NETO1 SIPA1L1 BSN DCLK1	8.38e-05	523	108	11	GO:0098984
GeneOntologyCellularComponent	Schaffer collateral - CA1 synapse	IQSEC2 DCC GRM5 PICALM NETO1 BSN	1.55e-04	155	108	6	GO:0098685
GeneOntologyCellularComponent	keratohyalin granule	FLG FLG2	2.62e-04	5	108	2	GO:0036457
GeneOntologyCellularComponent	growth cone	APC TSC1 DCC STIM1 CDKL5 CCDC120 DCLK1	2.85e-04	245	108	7	GO:0030426
GeneOntologyCellularComponent	site of polarized growth	APC TSC1 DCC STIM1 CDKL5 CCDC120 DCLK1	3.46e-04	253	108	7	GO:0030427
GeneOntologyCellularComponent	axon	DIP2B APC TSC1 DCC ADCY9 STIM1 CDKL5 SYNJ2 NETO1 NAV1 CCDC120 BSN DCLK1	6.85e-04	891	108	13	GO:0030424
GeneOntologyCellularComponent	postsynapse	SYNE1 IQSEC2 APC TSC1 DCC GRM5 PICALM SLITRK1 CDKL5 SLITRK2 NETO1 SIPA1L1 BSN DCLK1	7.55e-04	1018	108	14	GO:0098794
GeneOntologyCellularComponent	synaptic membrane	PODXL SYNE1 IQSEC2 DCC GRM5 PICALM SLITRK1 SLITRK2 NETO1 BSN	8.82e-04	583	108	10	GO:0097060
GeneOntologyCellularComponent	glutamatergic synapse	PODXL IQSEC2 APC GRM5 SLITRK1 CDKL5 SLITRK2 NETO1 SIPA1L1 BSN SIPA1L2 DCLK1	1.05e-03	817	108	12	GO:0098978
GeneOntologyCellularComponent	postsynaptic membrane	SYNE1 IQSEC2 DCC GRM5 PICALM SLITRK1 SLITRK2 NETO1	1.21e-03	405	108	8	GO:0045211
GeneOntologyCellularComponent	postsynaptic density membrane	IQSEC2 DCC GRM5 SLITRK1 NETO1	1.34e-03	157	108	5	GO:0098839
GeneOntologyCellularComponent	distal axon	APC TSC1 DCC STIM1 CDKL5 SYNJ2 CCDC120 DCLK1	1.89e-03	435	108	8	GO:0150034
GeneOntologyCellularComponent	polymeric cytoskeletal fiber	DCDC2 KRT10 APC TSC1 PSTPIP1 STIM1 ARHGAP6 SYNJ2 TTLL11 NAV3 NAV1 CAMSAP2	2.34e-03	899	108	12	GO:0099513
GeneOntologyCellularComponent	Golgi lumen	MUC19 MUC16 MUC12 MUC4	2.47e-03	109	108	4	GO:0005796
Domain	Rap_GAP_dom	RALGAPB SIPA1L1 SIPA1L2	2.92e-05	11	107	3	IPR000331
Domain	RAPGAP	RALGAPB SIPA1L1 SIPA1L2	2.92e-05	11	107	3	PS50085
Domain	Filaggrin	FLG FLG2	3.25e-05	2	107	2	IPR003303
Domain	BROMODOMAIN_2	BAZ2B TRIM24 KMT2A BRWD1	8.76e-05	41	107	4	PS50014
Domain	Bromodomain	BAZ2B TRIM24 KMT2A BRWD1	9.64e-05	42	107	4	IPR001487
Domain	BROMO	BAZ2B TRIM24 KMT2A BRWD1	9.64e-05	42	107	4	SM00297
Domain	-	BAZ2B TRIM24 KMT2A BRWD1	9.64e-05	42	107	4	1.20.920.10
Domain	SPAR_C	SIPA1L1 SIPA1L2	9.72e-05	3	107	2	PF11881
Domain	SIPA1L_C	SIPA1L1 SIPA1L2	9.72e-05	3	107	2	IPR021818
Domain	Znf_FYVE_PHD	BAZ2B TRIM24 PIKFYVE KMT2A BSN KAT6B	2.02e-04	147	107	6	IPR011011
Domain	Bromodomain_CS	BAZ2B TRIM24 BRWD1	4.32e-04	26	107	3	IPR018359
Domain	PQQ	ERN1 ZNF106	4.80e-04	6	107	2	SM00564
Domain	DCX	DCDC2 DCLK1	4.80e-04	6	107	2	SM00537
Domain	PQQ_repeat	ERN1 ZNF106	4.80e-04	6	107	2	IPR002372
Domain	PQQ_beta_propeller_repeat	ERN1 ZNF106	4.80e-04	6	107	2	IPR018391
Domain	-	DCDC2 DCLK1	6.70e-04	7	107	2	3.10.20.230
Domain	DCX	DCDC2 DCLK1	6.70e-04	7	107	2	PF03607
Domain	DC	DCDC2 DCLK1	8.90e-04	8	107	2	PS50309
Domain	Doublecortin_dom	DCDC2 DCLK1	8.90e-04	8	107	2	IPR003533
Domain	PHD	BAZ2B TRIM24 KMT2A KAT6B	9.05e-04	75	107	4	PF00628
Domain	Znf_PHD-finger	BAZ2B TRIM24 KMT2A KAT6B	1.10e-03	79	107	4	IPR019787
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DIP2B DENND4A KIAA0232 IQSEC2 RALGAPB APC WNK1 RGS12 E2F8 STIM1 NHSL1 ZNF106 DENND1B ALMS1 NKD2 FRMD6 SYNJ2 SIPA1L1 MARK4 AGFG1 NAV1 KMT2A PLCH1 SIPA1L2 DNMBP SRRM2 CAMSAP2 DCLK1 TNS3	1.33e-21	861	112	29	36931259
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	TUT4 APC TSC1 WNK1 ADCY9 SLC3A2 PIKFYVE ZNF106 ALMS1 SYNJ2 AMOTL1 NFRKB AGFG1 NAV1 UGGT2 PLCH1 TNS3	2.22e-10	733	112	17	34672954
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ATMIN SYNE1 KIAA0232 RALGAPB TSC1 SIPA1L1 MARK4 NAV3 NAV1 MAPKBP1 SIPA1L2 SRRM2 CAMSAP2	7.61e-10	407	112	13	12693553
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	DCDC2 SYNE1 KIAA0232 RALGAPB WNK1 ZBTB24 ADCY9 ALMS1 SIPA1L1 KAT6B	3.35e-09	225	112	10	12168954
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	DENND4A APC PICALM NHSL1 ALMS1 SIPA1L1 SIPA1L2 CAMSAP2 TNS3	2.77e-08	209	112	9	36779422
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	TUT4 IQSEC2 PER1 APC GRM5 SLC3A2 STIM1 NHSL1 CDKL5 CELSR2 SIPA1L1 NAV3 NAV1 BSN SIPA1L2 CAMSAP2 DCLK1	1.47e-07	1139	112	17	36417873
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	DIP2B RALGAPB BLM CCNT2 ZNF106 GTF3C1 SIPA1L1 NFRKB RBM15B KMT2A IRF2BPL KAT6B DNMBP SRRM2	2.09e-07	774	112	14	15302935
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC19 MUC16 MUC12 MUC4	3.01e-07	18	112	4	18834073
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	DIP2B PODXL TSC1 RGS12 ADCY9 SLC3A2 CDKL5 SLITRK2 PIEZO2 CELSR2 NAV1 TNS3	3.28e-07	569	112	12	30639242
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	DCDC2 APC MARCHF7 WNK1 ZBTB24 E2F8 NPHP3 AOPEP SIPA1L1 OR10AD1 NFRKB HERC1 DCLK1 AFF4 BRWD1 ZNF445	4.10e-07	1084	112	16	11544199
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	DIP2B SYNE1 IQSEC2 APC TSC1 GRM5 PICALM CELSR2 NETO1 SIPA1L1 NAV1 BSN CAMSAP2 DCLK1 AFF4	4.99e-07	963	112	15	28671696
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CMTR1 BAZ2B PER1 WNK1 SLITRK1 PIKFYVE NPHP3 ALMS1 IRF2BPL PLCH1 MAST3	6.02e-07	493	112	11	15368895
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	WNK1 ALMS1 SYNJ2 KAT6B SRRM2 DCLK1	1.14e-06	104	112	6	9205841
Pubmed	Endofin is required for HD-PTP and ESCRT-0 interdependent endosomal sorting of ubiquitinated transmembrane cargoes.	WNK1 PICALM ALMS1 AGFG1 DNMBP	1.50e-06	60	112	5	34761192
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	FLG PODXL IQSEC2 APC TRIM24 PICALM SLC3A2 STIM1 NHSL1 NKD2 AMOTL1 IRF2BPL	2.41e-06	689	112	12	36543142
Pubmed	The protein interaction landscape of the human CMGC kinase group.	ERN1 KIAA0232 APC CDKL5 CCNT2 ALMS1 SIPA1L1 NAV1 DMBT1 SIPA1L2 SRRM2 AFF4	2.64e-06	695	112	12	23602568
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	APC TSC1 WNK1 BLM PIKFYVE ALMS1 AGFG1 NAV1 BSN SIPA1L2 DNMBP	3.30e-06	588	112	11	38580884
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	KRT10 SYNE1 IQSEC2 APC TSC1 GRM5 SLC3A2 NHSL1 CDKL5 SIPA1L1 NAV1 KMT2A BSN PLCH1 SIPA1L2 CAMSAP2 DCLK1	3.36e-06	1431	112	17	37142655
Pubmed	A human MAP kinase interactome.	SYNE1 KIAA0232 APC MUC12 WNK1 ZNF106 SYNJ2 NAV3 AGFG1 NAV1	4.11e-06	486	112	10	20936779
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ATMIN DIP2B TCF3 DCAF6 TUT4 KIAA0232 RALGAPB ARHGAP6 DENND1B GTF3C1 SYNJ2 NETO1 AOPEP TTLL11 NAV1 KAT6B AFF4	5.69e-06	1489	112	17	28611215
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	KRT10 PODXL APC MUC16 FLG2 ADCY9 SLC3A2 BLM STIM1 CDKL5 FRMD6 AMOTL1	8.16e-06	777	112	12	35844135
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	RALGAPB PICALM ADCY9 SLC3A2 STIM1 NHSL1 CELSR2 PLCH1 SIPA1L2	9.38e-06	421	112	9	36976175
Pubmed	Concurrent activation of growth factor and nutrient arms of mTORC1 induces oxidative liver injury.	TSC1 DEPDC5	1.03e-05	2	112	2	31754457
Pubmed	Slitrk1 is localized to excitatory synapses and promotes their development.	SLITRK1 SLITRK2	1.03e-05	2	112	2	27273464
Pubmed	DCC constrains tumour progression via its dependence receptor activity.	APC DCC	1.03e-05	2	112	2	22158121
Pubmed	A novel chromosomal inversion at 11q23 in infant acute myeloid leukemia fuses MLL to CALM, a gene that encodes a clathrin assembly protein.	PICALM KMT2A	1.03e-05	2	112	2	12461747
Pubmed	Identification of a novel putative gastrointestinal stem cell and adenoma stem cell marker, doublecortin and CaM kinase-like-1, following radiation injury and in adenomatous polyposis coli/multiple intestinal neoplasia mice.	APC DCLK1	1.03e-05	2	112	2	18055444
Pubmed	Cancer predisposition caused by elevated mitotic recombination in Bloom mice.	APC BLM	1.03e-05	2	112	2	11101838
Pubmed	Intestinal epithelial cell-specific CD98 expression regulates tumorigenesis in Apc(Min/+) mice.	APC SLC3A2	1.03e-05	2	112	2	22641098
Pubmed	Posttranscriptional regulation of PER1 underlies the oncogenic function of IREα.	ERN1 PER1	1.03e-05	2	112	2	23752693
Pubmed	The ER stress sensor IRE1 interacts with STIM1 to promote store-operated calcium entry, T cell activation, and muscular differentiation.	ERN1 STIM1	1.03e-05	2	112	2	38060449
Pubmed	Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology.	MUC16 MUC4	1.03e-05	2	112	2	23544943
Pubmed	Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells.	APC DCLK1	1.03e-05	2	112	2	28148261
Pubmed	TSC1 and DEPDC5 regulate HIV-1 latency through the mTOR signaling pathway.	TSC1 DEPDC5	1.03e-05	2	112	2	30087333
Pubmed	Inducible cAMP early repressor regulates the Period 1 gene of the hepatic and adrenal clocks.	PER1 CREM	1.03e-05	2	112	2	23443664
Pubmed	Depletion of transmembrane mucin 4 (Muc4) alters intestinal homeostasis in a genetically engineered mouse model of colorectal cancer.	APC MUC4	1.03e-05	2	112	2	35255004
Pubmed	DCLK1 facilitates intestinal tumor growth via enhancing pluripotency and epithelial mesenchymal transition.	APC DCLK1	1.03e-05	2	112	2	25211188
Pubmed	Enhanced tumor formation in mice heterozygous for Blm mutation.	APC BLM	1.03e-05	2	112	2	12242442
Pubmed	Simultaneous loss of TSC1 and DEPDC5 in skeletal and cardiac muscles produces early-onset myopathy and cardiac dysfunction associated with oxidative damage and SQSTM1/p62 accumulation.	TSC1 DEPDC5	1.03e-05	2	112	2	34964695
Pubmed	Induction of renal tumorigenesis with elevated levels of somatic loss of heterozygosity in Tsc1+/- mice on a Blm-deficient background.	TSC1 BLM	1.03e-05	2	112	2	16288003
Pubmed	Expression of filaggrin-2 protein in the epidermis of human skin diseases: a comparative analysis with filaggrin.	FLG FLG2	1.03e-05	2	112	2	24813994
Pubmed	Wnt signaling regulates the lineage differentiation potential of mouse embryonic stem cells through Tcf3 down-regulation.	TCF3 APC	1.03e-05	2	112	2	23658527
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	PER1 APC SIPA1L1 NAV1 PLCH1 SIPA1L2 MXI1	1.07e-05	232	112	7	25515538
Pubmed	MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia.	CCNT2 KMT2A AFF4	1.15e-05	14	112	3	20854876
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ATMIN PER1 WNK1 ADCY9 PIKFYVE NHSL1 CELSR2 MARK4 NAV1 DEPDC5 HERC1 MAPKBP1 SIPA1L2 DNMBP	1.31e-05	1105	112	14	35748872
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	DCAF6 TUT4 PER1 TRIM24 ADCY9 ALMS1 SIPA1L1 MARK4 NFRKB SIPA1L2 KAT6B SRRM2 AFF4 BRWD1	1.46e-05	1116	112	14	31753913
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	DENND4A RALGAPB APC WNK1 ALMS1 SIPA1L1 AMOTL1 NAV1 SIPA1L2	1.48e-05	446	112	9	24255178
Pubmed	Prediction of the coding sequences of unidentified human genes. VIII. 78 new cDNA clones from brain which code for large proteins in vitro.	ATMIN ZBTB24 SIPA1L1 BSN	2.45e-05	52	112	4	9455477
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	KRT10 BAZ2B TRIM24 ZBTB24 BLM GTF3C1 NFRKB KMT2A AFF4 BRWD1	2.84e-05	608	112	10	36089195
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	TRIM24 ALMS1 SIPA1L1 NFRKB NAV1 CAMSAP2	3.04e-05	184	112	6	32908313
Pubmed	Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model.	MUC16 MUC4	3.08e-05	3	112	2	23053434
Pubmed	Tsc1 haploinsufficiency without mammalian target of rapamycin activation is sufficient for renal cyst formation in Tsc1+/- mice.	TSC1 BLM	3.08e-05	3	112	2	16912167
Pubmed	Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.	MUC16 MUC4	3.08e-05	3	112	2	30236127
Pubmed	Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis.	MUC16 MUC12	3.08e-05	3	112	2	26770020
Pubmed	A relay mechanism between EB1 and APC facilitate STIM1 puncta assembly at endoplasmic reticulum-plasma membrane junctions.	APC STIM1	3.08e-05	3	112	2	23871111
Pubmed	GATA3 regulates FLG and FLG2 expression in human primary keratinocytes.	FLG FLG2	3.08e-05	3	112	2	28928464
Pubmed	Clinical and genetic findings in an Ashkenazi Jewish population with colorectal neoplasms.	APC BLM	3.08e-05	3	112	2	15959913
Pubmed	A new homozygous HERC1 gain-of-function variant in MDFPMR syndrome leads to mTORC1 hyperactivation and reduced autophagy during cell catabolism.	TSC1 HERC1	3.08e-05	3	112	2	32921582
Pubmed	Filaggrin and filaggrin 2 processing are linked together through skin aspartic acid protease activation.	FLG FLG2	3.08e-05	3	112	2	32437351
Pubmed	RapGAPs in brain: multipurpose players in neuronal Rap signalling.	SIPA1L1 SIPA1L2	3.08e-05	3	112	2	20576033
Pubmed	Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling).	MUC16 MUC4	3.08e-05	3	112	2	27483328
Pubmed	MicroRNA-200c modulates the expression of MUC4 and MUC16 by directly targeting their coding sequences in human pancreatic cancer.	MUC16 MUC4	3.08e-05	3	112	2	24204560
Pubmed	Expression of the transmembrane mucins, MUC1, MUC4 and MUC16, in normal endometrium and in endometriosis.	MUC16 MUC4	3.08e-05	3	112	2	24939955
Pubmed	TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase.	TSC1 HERC1	3.08e-05	3	112	2	16464865
Pubmed	ER stress transcription factor Xbp1 suppresses intestinal tumorigenesis and directs intestinal stem cells.	ERN1 APC	3.08e-05	3	112	2	24043762
Pubmed	Expression of mucin (MUC) genes in mucoepidermoid carcinoma.	MUC19 MUC4	3.08e-05	3	112	2	21072847
Pubmed	Copy number of the Adenomatous Polyposis Coli gene is not always neutral in sporadic colorectal cancers with loss of heterozygosity for the gene.	APC DCC	3.08e-05	3	112	2	26970738
Pubmed	Rett-like phenotypes: expanding the genetic heterogeneity to the KCNA2 gene and first familial case of CDKL5-related disease.	IQSEC2 CDKL5	3.08e-05	3	112	2	27062609
Pubmed	Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone.	MUC16 MUC4	3.08e-05	3	112	2	17592322
Pubmed	Neuron navigator: a human gene family with homology to unc-53, a cell guidance gene from Caenorhabditis elegans.	NAV3 NAV1	3.08e-05	3	112	2	12079279
Pubmed	Sensory deficits in mice hypomorphic for a mammalian homologue of unc-53.	NAV3 NAV1	3.08e-05	3	112	2	15158073
Pubmed	Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin.	FLG FLG2	3.08e-05	3	112	2	23403047
Pubmed	Recurrent YAP1 and KMT2A Gene Rearrangements in a Subset of MUC4-negative Sclerosing Epithelioid Fibrosarcoma.	KMT2A MUC4	3.08e-05	3	112	2	31592798
Pubmed	Pore membrane and/or filament interacting like protein 1 (POMFIL1) is predominantly expressed in the nervous system and encodes different protein isoforms.	NAV3 NAV1	3.08e-05	3	112	2	12062803
Pubmed	Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection.	MUC16 MUC4	3.08e-05	3	112	2	35879412
Pubmed	Long-lived intestinal tuft cells serve as colon cancer-initiating cells.	APC DCLK1	3.08e-05	3	112	2	24487592
Pubmed	AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23).	KMT2A AFF4	3.08e-05	3	112	2	10588740
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	TSC1 SLITRK1 RGS12 BLM ZNF106 GTF3C1 KMT2A HERC1 MUC4	3.46e-05	497	112	9	36774506
Pubmed	Nephronophthisis-Related Ciliopathies	DCDC2 NPHP3 MAPKBP1	4.14e-05	21	112	3	27336129
Pubmed	HENA, heterogeneous network-based data set for Alzheimer's disease.	SYNE1 APC ALMS1 NAV1 ZNF445	4.49e-05	120	112	5	31413325
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	FLG DIP2B KRT10 SYNE1 APC FLG2 BLM CCNT2 GTF3C1 RBM15B SIPA1L2 SRRM2 AFF4	4.70e-05	1082	112	13	38697112
Pubmed	DYRK1A regulates the recruitment of 53BP1 to the sites of DNA damage in part through interaction with RNF169.	KIAA0232 TSC1 PICALM SIPA1L1 SIPA1L2	4.86e-05	122	112	5	30773093
Pubmed	Distinct kinetic and mechanical properties govern mucin 16- and podocalyxin-mediated tumor cell adhesion to E- and L-selectin in shear flow.	PODXL MUC16	6.14e-05	4	112	2	26329844
Pubmed	TRPV4 activation in human corneal epithelial cells promotes membrane mucin production.	MUC16 MUC4	6.14e-05	4	112	2	39024979
Pubmed	Netrin-DCC signaling regulates corpus callosum formation through attraction of pioneering axons and by modulating Slit2-mediated repulsion.	APC DCC	6.14e-05	4	112	2	23302812
Pubmed	Brg1 is required to maintain colorectal cancer stem cells.	APC DCLK1	6.14e-05	4	112	2	34415580
Pubmed	Analysis of mutations in TP53, APC, K-ras, and DCC genes in the non-dysplastic mucosa of patients with inflammatory bowel disease.	APC DCC	6.14e-05	4	112	2	19543899
Pubmed	A novel Zinc finger protein, ZCCHC11, interacts with TIFA and modulates TLR signaling.	TUT4 TRIM24	6.14e-05	4	112	2	16643855
Pubmed	Transcription factors TEAD2 and E2A globally repress acetyl-CoA synthesis to promote tumorigenesis.	TCF3 TSC1	6.14e-05	4	112	2	36400009
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	FLG KRT10 DENND4A SYNE1 TSC1 DCC SLC3A2 MYPOP GTF3C1 KMT2A UGGT2 BSN PLCH1 SIPA1L2 CAMSAP2	6.16e-05	1442	112	15	35575683
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	ALMS1 SYNJ2 SIPA1L1 NAV1 MAST3	6.58e-05	130	112	5	12421765
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	DIP2B PIKFYVE NHSL1 SIPA1L1 BSN SIPA1L2	7.79e-05	218	112	6	33378226
Pubmed	In Vitro Identification of Histatin 5 Salivary Complexes.	FLG DMBT1 PLCH1	8.99e-05	27	112	3	26544073
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	FLG DENND4A IQSEC2 WNK1 BLM STIM1 NPHP3 SIPA1L1 AMOTL1 NAV1 UGGT2 CAMSAP2 DCLK1 MAST3	9.07e-05	1321	112	14	27173435
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	PICALM ADCY9 SLC3A2 STIM1 NHSL1 CDKL5 SYNJ2 AGFG1 CCDC120	9.23e-05	565	112	9	25468996
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	ATMIN RALGAPB MARCHF7 TSC1 MUC12 WNK1 CREM CCNT2 ZNF106 OR4K1 NFRKB KMT2A CCDC120 DEPDC5	9.52e-05	1327	112	14	32694731
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	KIAA0232 APC TSC1 RGS12 ALMS1 SYNJ2 SIPA1L1 SIPA1L2 DNMBP CAMSAP2 BRWD1	1.00e-04	853	112	11	28718761
Pubmed	LINC complexes form by binding of three KASH peptides to domain interfaces of trimeric SUN proteins.	SYNE1 AOPEP	1.02e-04	5	112	2	22632968
Pubmed	Dclk1 distinguishes between tumor and normal stem cells in the intestine.	APC DCLK1	1.02e-04	5	112	2	23202126
Pubmed	The mTOR pathway genes MTOR, Rheb, Depdc5, Pten, and Tsc1 have convergent and divergent impacts on cortical neuron development and function.	TSC1 DEPDC5	1.02e-04	5	112	2	38411613
Interaction	YWHAH interactions	DIP2B DENND4A KIAA0232 IQSEC2 RALGAPB APC TSC1 WNK1 RGS12 E2F8 STIM1 NHSL1 ZNF106 DENND1B ALMS1 NKD2 FRMD6 SYNJ2 SIPA1L1 MARK4 RBM15B AGFG1 NAV1 KMT2A HERC1 PLCH1 SIPA1L2 DNMBP SRRM2 CAMSAP2 DCLK1 MAST3 TNS3	3.02e-16	1102	110	33	int:YWHAH
Interaction	YWHAG interactions	DENND4A KIAA0232 IQSEC2 RALGAPB APC TSC1 WNK1 RGS12 E2F8 STIM1 NHSL1 ZNF106 DENND1B ALMS1 NKD2 FRMD6 SYNJ2 SIPA1L1 MARK4 RBM15B AGFG1 NAV1 KMT2A PLCH1 SIPA1L2 DNMBP SRRM2 CAMSAP2 DCLK1 MAST3 TNS3	4.56e-13	1248	110	31	int:YWHAG
Interaction	YWHAB interactions	DENND4A KIAA0232 IQSEC2 RALGAPB APC TSC1 WNK1 RGS12 E2F8 STIM1 NHSL1 ZNF106 DENND1B NKD2 FRMD6 SYNJ2 SIPA1L1 MARK4 NAV1 KMT2A PLCH1 SIPA1L2 DNMBP SRRM2 CAMSAP2 DCLK1 MAST3 TNS3	6.42e-13	1014	110	28	int:YWHAB
Interaction	YWHAE interactions	DENND4A KIAA0232 IQSEC2 RALGAPB APC TSC1 WNK1 RGS12 E2F8 STIM1 ZNF106 DENND1B NKD2 FRMD6 SYNJ2 SIPA1L1 AMOTL1 MARK4 NAV1 KMT2A DEPDC5 PLCH1 SIPA1L2 DNMBP SRRM2 CAMSAP2 DCLK1 MAST3	1.02e-10	1256	110	28	int:YWHAE
Interaction	SFN interactions	TCF3 KRT10 DENND4A KIAA0232 APC WNK1 RGS12 DENND1B ALMS1 FRMD6 SYNJ2 SIPA1L1 NAV1 KMT2A PLCH1 SIPA1L2 DNMBP SRRM2 CAMSAP2 TNS3	9.58e-10	692	110	20	int:SFN
Interaction	YWHAQ interactions	TCF3 DENND4A IQSEC2 APC TSC1 WNK1 RGS12 E2F8 NHSL1 ZNF106 DENND1B NKD2 FRMD6 SYNJ2 SIPA1L1 AGFG1 NAV1 KMT2A PLCH1 SIPA1L2 DNMBP CAMSAP2 DCLK1 TNS3	6.07e-09	1118	110	24	int:YWHAQ
Interaction	YWHAZ interactions	DENND4A KIAA0232 IQSEC2 RALGAPB APC TSC1 WNK1 RGS12 E2F8 STIM1 NHSL1 DENND1B NKD2 FRMD6 SIPA1L1 AMOTL1 MARK4 NAV1 KMT2A DEPDC5 PLCH1 SIPA1L2 DNMBP CAMSAP2 DCLK1 MAST3	7.31e-09	1319	110	26	int:YWHAZ
Interaction	AFDN interactions	APC ADCY9 SLC3A2 CDKL5 FRMD6 SIPA1L1 AMOTL1 KMT2A PLCH1 SIPA1L2 DNMBP DCLK1	2.81e-07	333	110	12	int:AFDN
Interaction	PPM1H interactions	DENND4A TSC1 BLM SIPA1L1 NAV1 CAMSAP2 DCLK1 MAST3	3.73e-07	123	110	8	int:PPM1H
Interaction	MAPRE3 interactions	DIP2B DCDC2 APC MARCHF7 STIM1 SYNJ2 NAV1 DNMBP CAMSAP2 DCLK1	5.34e-07	230	110	10	int:MAPRE3
Interaction	PFN1 interactions	RALGAPB APC TSC1 WNK1 TRIM24 NHSL1 MYPOP ALMS1 SYNJ2 NAV1 UGGT2 SIPA1L2 DNMBP AFF4	7.19e-07	509	110	14	int:PFN1
Interaction	DENND1A interactions	DENND4A PICALM SIPA1L1 NAV1 CAMSAP2 DCLK1 MAST3	1.34e-06	101	110	7	int:DENND1A
Interaction	INPP5E interactions	DENND4A SIPA1L1 NAV1 CAMSAP2 DCLK1 MAST3	1.47e-06	65	110	6	int:INPP5E
Interaction	LRFN1 interactions	DENND4A SLC3A2 SIPA1L1 NAV1 CAMSAP2 DCLK1 MAST3	5.30e-06	124	110	7	int:LRFN1
Interaction	DRC3 interactions	MUC19 PER1 MARCHF7 ALMS1	6.87e-06	23	110	4	int:DRC3
Interaction	MAST3 interactions	DENND4A CCNT2 SIPA1L1 NAV1 CAMSAP2 DCLK1 MAST3	6.88e-06	129	110	7	int:MAST3
Interaction	GSK3A interactions	DCAF6 DENND4A APC PICALM CREM NHSL1 ALMS1 SIPA1L1 SIPA1L2 SRRM2 CAMSAP2 TNS3	8.80e-06	464	110	12	int:GSK3A
Interaction	TESK2 interactions	DENND4A SIPA1L1 NAV1 CAMSAP2 DCLK1 MAST3	1.52e-05	97	110	6	int:TESK2
Interaction	RTKN interactions	DENND4A SIPA1L1 NAV1 CAMSAP2 DCLK1 MAST3	4.00e-05	115	110	6	int:RTKN
Interaction	C2CD4A interactions	KIAA0232 CELSR2 HERC1	4.35e-05	13	110	3	int:C2CD4A
Interaction	KRT38 interactions	APC TSC1 TRIM24 ALMS1 NAV1 CCDC120 MAPKBP1	4.44e-05	172	110	7	int:KRT38
Interaction	SIPA1L1 interactions	DENND4A SIPA1L1 NAV1 SIPA1L2 CAMSAP2 DCLK1 MAST3	4.78e-05	174	110	7	int:SIPA1L1
Interaction	PIP interactions	TCF3 KIAA0232 TRIM24 PICALM NPHP3 SIPA1L1 AGFG1	6.13e-05	181	110	7	int:PIP
Interaction	DCLK1 interactions	DENND4A SIPA1L1 NAV1 CAMSAP2 DCLK1 MAST3	6.98e-05	127	110	6	int:DCLK1
Interaction	SH3PXD2A interactions	DENND4A SIPA1L1 NAV1 CAMSAP2 DCLK1 MAST3	7.29e-05	128	110	6	int:SH3PXD2A
Interaction	NADK interactions	SIPA1L1 NAV1 CAMSAP2 DCLK1 MAST3	7.67e-05	80	110	5	int:NADK
Interaction	SRSF12 interactions	DENND4A SIPA1L1 NAV1 CAMSAP2 DCLK1 MAST3	7.94e-05	130	110	6	int:SRSF12
Interaction	KSR1 interactions	DENND4A SIPA1L1 NAV1 CAMSAP2 DCLK1 MAST3	8.64e-05	132	110	6	int:KSR1
Interaction	NAV2 interactions	APC PSTPIP1 RBM15B NAV3	8.80e-05	43	110	4	int:NAV2
Interaction	TRIM52 interactions	MARCHF7 TRIM24 GTF3C1 ALMS1 SIPA1L2 ZNF445	9.01e-05	133	110	6	int:TRIM52
Interaction	C2CD4B interactions	KIAA0232 APC CELSR2 HERC1	9.64e-05	44	110	4	int:C2CD4B
Interaction	METTL6 interactions	DENND4A WNK1 STIM1	1.02e-04	17	110	3	int:METTL6
Interaction	SRGAP2 interactions	DENND4A SIPA1L1 NAV1 DNMBP CAMSAP2 DCLK1 MAST3	1.04e-04	197	110	7	int:SRGAP2
Interaction	MAPRE1 interactions	DIP2B APC MARCHF7 STIM1 ALMS1 SYNJ2 NAV3 NAV1 DNMBP SRRM2 CAMSAP2	1.17e-04	514	110	11	int:MAPRE1
Interaction	DENND4C interactions	DENND4A SIPA1L1 NAV1 CAMSAP2 DCLK1 MAST3	1.20e-04	140	110	6	int:DENND4C
Interaction	KIF13B interactions	DENND4A SIPA1L1 NAV1 CAMSAP2 DCLK1 MAST3	1.29e-04	142	110	6	int:KIF13B
Interaction	MAGI1 interactions	DENND4A SIPA1L1 NAV1 CAMSAP2 DCLK1 MAST3	1.56e-04	147	110	6	int:MAGI1
Interaction	SYNE3 interactions	APC TSC1 PICALM ADCY9 STIM1 ALMS1 SIPA1L1 NAV1 UGGT2 SIPA1L2	1.60e-04	444	110	10	int:SYNE3
Interaction	STX6 interactions	DENND4A RALGAPB TSC1 CHST9 PICALM ADCY9 SLC3A2 STIM1 GTF3C1 AGFG1	1.72e-04	448	110	10	int:STX6
Interaction	PRNP interactions	FLG BAZ2B PODXL IQSEC2 APC GRM5 TRIM24 PICALM SLC3A2 STIM1 NHSL1 NKD2 AMOTL1 MARK4 IRF2BPL BSN SRRM2	1.75e-04	1158	110	17	int:PRNP
Interaction	GTSE1 interactions	CMTR1 PER1 WNK1 PICALM ZNF106 DNMBP CAMSAP2	1.79e-04	215	110	7	int:GTSE1
Interaction	CGN interactions	DENND4A SIPA1L1 NAV1 CAMSAP2 DCLK1 MAST3	1.87e-04	152	110	6	int:CGN
Interaction	HSD17B7P2 interactions	DENND4A KIAA0232 SIPA1L2	1.96e-04	21	110	3	int:HSD17B7P2
Interaction	ZNF543 interactions	TRIM24 FRMD6 ZNF445	1.96e-04	21	110	3	int:ZNF543
Interaction	FGFRL1 interactions	KIAA0232 FLG2 CELSR2 KMT2A	2.00e-04	53	110	4	int:FGFRL1
Interaction	RAB4A interactions	DENND4A PODXL SYNE1 RALGAPB TSC1 ADCY9 SLC3A2 STIM1 PIKFYVE AGFG1	2.02e-04	457	110	10	int:RAB4A
Interaction	VASP interactions	DIP2B NHSL1 ALMS1 SYNJ2 SIPA1L1 SIPA1L2 DNMBP CAMSAP2	2.11e-04	294	110	8	int:VASP
Interaction	ZBTB21 interactions	DENND4A SIPA1L1 NAV1 CAMSAP2 DCLK1 MAST3	2.56e-04	161	110	6	int:ZBTB21
Interaction	GSK3B interactions	DENND4A APC TSC1 PICALM CREM SLC3A2 NHSL1 CABYR ALMS1 SIPA1L1 DMBT1 SIPA1L2 CAMSAP2 TNS3	2.69e-04	868	110	14	int:GSK3B
Interaction	KCTD3 interactions	DENND4A SIPA1L1 NAV1 CAMSAP2 DCLK1 MAST3	2.82e-04	164	110	6	int:KCTD3
Interaction	KLHL40 interactions	PER1 MARCHF7 ZNF106 NFRKB	3.04e-04	59	110	4	int:KLHL40
Interaction	AMOT interactions	APC ALMS1 SIPA1L1 AMOTL1 NAV1 SIPA1L2 DNMBP CAMSAP2	3.15e-04	312	110	8	int:AMOT
Interaction	DUSP16 interactions	TUT4 KIAA0232 PER1 ALMS1 NAV1 PLCH1 SIPA1L2	3.24e-04	237	110	7	int:DUSP16
Interaction	SYDE1 interactions	SIPA1L1 NAV1 CAMSAP2 DCLK1 MAST3	3.43e-04	110	110	5	int:SYDE1
Interaction	CCNT2 interactions	CCNT2 RBM15B AFF4 MAST3	3.67e-04	62	110	4	int:CCNT2
Interaction	ADAMTS13 interactions	KIAA0232 CELSR2 HERC1	3.75e-04	26	110	3	int:ADAMTS13
Interaction	GIGYF1 interactions	DENND4A SIPA1L1 NAV1 CAMSAP2 DCLK1 MAST3	4.25e-04	177	110	6	int:GIGYF1
Interaction	NXF2 interactions	PER1 ZNF106 SIPA1L2 ZNF445	4.40e-04	65	110	4	int:NXF2
Interaction	AGAP1 interactions	SIPA1L1 NAV1 CAMSAP2 DCLK1 MAST3	4.56e-04	117	110	5	int:AGAP1
Interaction	CBY1 interactions	DENND4A SIPA1L1 NAV1 CAMSAP2 DCLK1 MAST3	4.92e-04	182	110	6	int:CBY1
Interaction	PLEKHA7 interactions	SIPA1L1 DNMBP CAMSAP2 DCLK1 MAST3	4.93e-04	119	110	5	int:PLEKHA7
Interaction	FAM110B interactions	PER1 SIPA1L1 DCLK1 MAST3	4.94e-04	67	110	4	int:FAM110B
Interaction	KIF1C interactions	TSC1 SIPA1L1 CAMSAP2 DCLK1 MAST3	5.12e-04	120	110	5	int:KIF1C
Interaction	FBXO42 interactions	APC TSC1 WNK1 PIKFYVE ALMS1 AGFG1 NAV1	5.52e-04	259	110	7	int:FBXO42
Interaction	SAMD4B interactions	APC ALMS1 SIPA1L1 NAV1 SIPA1L2	5.52e-04	122	110	5	int:SAMD4B
Interaction	HTN3 interactions	FLG DMBT1 PLCH1	5.77e-04	30	110	3	int:HTN3
Interaction	GIGYF2 interactions	APC TRIM24 SIPA1L1 NAV1 CAMSAP2 DCLK1 MAST3	6.04e-04	263	110	7	int:GIGYF2
Interaction	ZBBX interactions	KIAA0232 CELSR2 HERC1	6.36e-04	31	110	3	int:ZBBX
Interaction	LPIN3 interactions	SIPA1L1 CAMSAP2 DCLK1 MAST3	6.85e-04	73	110	4	int:LPIN3
GeneFamily	CD molecules\|Mucins	MUC19 MUC16 MUC12 MUC4	1.63e-06	21	76	4	648
GeneFamily	EF-hand domain containing\|S100 fused type protein family	FLG FLG2	3.61e-04	7	76	2	1350
GeneFamily	PHD finger proteins	BAZ2B TRIM24 KMT2A KAT6B	5.60e-04	90	76	4	88
GeneFamily	Doublecortin superfamily	DCDC2 DCLK1	7.68e-04	10	76	2	1369
GeneFamily	WD repeat domain containing\|DDB1 and CUL4 associated factors	DCAF6 BRWD1	2.55e-03	18	76	2	498
GeneFamily	PDZ domain containing	RGS12 SIPA1L1 SIPA1L2 MAST3	3.85e-03	152	76	4	1220
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	TUT4 ERN1 WNK1 ZNF106 GTF3C1 CELSR2 SIPA1L1 DEPDC5 HERC1	6.57e-08	180	109	9	M8239
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	TUT4 BAZ2B PODXL APC MARCHF7 TRIM24 PICALM ADCY9 BLM PIKFYVE SYNJ2 SIPA1L1 NAV3 AGFG1 KAT6B DNMBP CAMSAP2	9.14e-08	856	109	17	M4500
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	DIP2B TUT4 MUC19 APC DCC ZBED10P GRM5 SLITRK1 PIEZO2 NETO1 NAV3 NAV1 IRF2BPL HERC1 BSN CAMSAP2 DCLK1 BRWD1	6.91e-07	1106	109	18	M39071
Coexpression	GRESHOCK_CANCER_COPY_NUMBER_UP	TCF3 PER1 APC TSC1 TRIM24 PICALM BLM KMT2A KAT6B AFF4	1.02e-06	323	109	10	M9150
Coexpression	GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_DN	TSC1 PHKA2 ARHGAP6 FRMD6 KMT2A BSN SRRM2 TNS3	1.96e-06	200	109	8	M8052
Coexpression	STARK_HYPPOCAMPUS_22Q11_DELETION_UP	NETO1 AOPEP BSN DCLK1 ZNF445	2.78e-06	53	109	5	MM582
Coexpression	STARK_HYPPOCAMPUS_22Q11_DELETION_UP	NETO1 AOPEP BSN DCLK1 ZNF445	3.05e-06	54	109	5	M12050
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	DENND4A TUT4 SYNE1 RALGAPB MARCHF7 PSTPIP1 ZNF831 WNK1 PICALM CREM STIM1 PIKFYVE CCNT2 DENND1B AGFG1 KMT2A HERC1 KAT6B MAST3 BRWD1	3.12e-06	1492	109	20	M40023
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	FLG TUT4 BAZ2B KIAA0232 ZBTB24 ADCY9 PIKFYVE NAV3 KAT6B	4.69e-06	300	109	9	M8702
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	ATMIN BAZ2B SYNE1 DCC ADCY9 E2F8 NHSL1 CCNT2 ALMS1 AOPEP NAV3 NAV1 CAMSAP2 DCLK1 MXI1 ZNF445	1.29e-05	1102	109	16	M2369
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	ATMIN BAZ2B SYNE1 DCC ADCY9 E2F8 NHSL1 CCNT2 ALMS1 AOPEP NAV3 NAV1 CAMSAP2 DCLK1 MXI1 ZNF445	1.65e-05	1124	109	16	MM1070
Coexpression	EGFR_UP.V1_DN	DCAF6 BAZ2B TRIM24 E2F8 SYCP2 CELSR2 AOPEP	1.84e-05	196	109	7	M2633
Coexpression	GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_45MIN_UP	RALGAPB TRIM24 PIKFYVE GTF3C1 FRMD6 CAMSAP2 MXI1	2.09e-05	200	109	7	M6618
Coexpression	GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP	TUT4 RALGAPB PIKFYVE NHSL1 ARHGAP6 GTF3C1 DEPDC5	2.09e-05	200	109	7	M8653
Coexpression	GSE11924_TH2_VS_TH17_CD4_TCELL_DN	TCF3 BAZ2B SLITRK1 RGS12 SLITRK2 FRMD6 CAMSAP2	2.09e-05	200	109	7	M3165
Coexpression	GSE11924_TFH_VS_TH2_CD4_TCELL_UP	BAZ2B MARCHF7 SYNJ2 UGGT2 DEPDC5 MAPKBP1 SRRM2	2.09e-05	200	109	7	M3153
Coexpression	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP	ERN1 BAZ2B PSTPIP1 WNK1 SLC3A2 STIM1 NPHP3 DENND1B ALMS1 UGGT2 IRF2BPL PLCH1 SIPA1L2	2.14e-05	778	109	13	M17915
Coexpression	GOZGIT_ESR1_TARGETS_DN	DCDC2 ERN1 CREM ADCY9 CDKL5 DENND1B CELSR2 FRMD6 AOPEP PLCH1 SIPA1L2 SRRM2 DCLK1	2.38e-05	786	109	13	M10961
Coexpression	STARK_BRAIN_22Q11_DELETION	AOPEP BSN ZNF445	2.46e-05	14	109	3	MM584
Coexpression	STARK_BRAIN_22Q11_DELETION	AOPEP BSN ZNF445	3.77e-05	16	109	3	M6139
Coexpression	GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP	PER1 DCC ZNF106 NPHP3 ALMS1 SYNJ2	6.74e-05	165	109	6	M337
Coexpression	SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_50_TO_60DY_UP	PER1 CREM STIM1 AGFG1 HERC1 MXI1	7.69e-05	169	109	6	M40877
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	TUT4 BAZ2B MARCHF7 PICALM BLM PIKFYVE KAT6B DNMBP CAMSAP2	1.46e-04	466	109	9	M13522
Coexpression	GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_DN	ERN1 WNK1 CREM SLC3A2 GTF3C1 SIPA1L1	1.46e-04	190	109	6	M384
Coexpression	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP	ERN1 BAZ2B PSTPIP1 WNK1 SLC3A2 STIM1 NPHP3 DENND1B ALMS1 UGGT2 IRF2BPL PLCH1 SIPA1L2	1.48e-04	942	109	13	M8144
Coexpression	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	INHBA BAZ2B RALGAPB PER1 MARCHF7 TSC1 ADAMTS5 SLC3A2 CCNT2 AFF4 MXI1 BRWD1	1.62e-04	822	109	12	M6782
Coexpression	GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP	RALGAPB TSC1 CCNT2 HERC1 KAT6B DCLK1	1.78e-04	197	109	6	M5378
Coexpression	GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_UP	BAZ2B BLM STIM1 SYCP2 PLCH1 SRRM2	1.78e-04	197	109	6	M5150
Coexpression	GSE42724_MEMORY_BCELL_VS_PLASMABLAST_UP	CMTR1 PER1 RGS12 AGFG1 KMT2A MXI1	1.88e-04	199	109	6	M9786
Coexpression	GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_UP	PODXL PER1 SLC3A2 MFSD14B RBM15B DEPDC5	1.93e-04	200	109	6	M7764
Coexpression	GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP	DIP2B ADCY9 RBM15B KMT2A HERC1 BRWD1	1.93e-04	200	109	6	M387
Coexpression	GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP	ATMIN DIP2B KRT10 PIKFYVE GTF3C1 AFF4	1.93e-04	200	109	6	M6613
Coexpression	GSE14350_IL2RB_KO_VS_WT_TEFF_UP	DIP2B PER1 PHKA2 MYPOP DCLK1 ZNF445	1.93e-04	200	109	6	M3423
Coexpression	GSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_UP	TCF3 ERN1 PODXL NHSL1 CABYR BMP15	1.93e-04	200	109	6	M9053
Coexpression	GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP	IQSEC2 SLC3A2 NFRKB IRF2BPL MAST3 ZNF445	1.93e-04	200	109	6	M8482
Coexpression	GSE38304_MYC_NEG_VS_POS_GC_BCELL_UP	BAZ2B CABYR ALMS1 FRMD6 NFRKB BRWD1	1.93e-04	200	109	6	M9273
Coexpression	GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_DN	CMTR1 IQSEC2 PSTPIP1 DENND1B SYNJ2 AOPEP	1.93e-04	200	109	6	M8781
Coexpression	GSE22886_IGA_VS_IGM_MEMORY_BCELL_DN	TSC1 PIEZO2 KMT2A DEPDC5 TNS3 BRWD1	1.93e-04	200	109	6	M4439
Coexpression	NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP	ATMIN TCF3 CMTR1 BAZ2B RALGAPB DEPDC5 SRRM2 BRWD1	2.68e-04	399	109	8	M41172
Coexpression	DAZARD_UV_RESPONSE_CLUSTER_G6	TUT4 ADCY9 PIKFYVE NAV3 KAT6B	3.56e-04	145	109	5	M1810
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D175\|Adult / Lineage, Cell type, age group and donor	ADAMTS5 GRM5 PIEZO2 FRMD6 NAV3 NAV1 DCLK1	5.03e-07	190	111	7	7dcca3469f3a3b70db0420cb94f7765f39492f06
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	DCDC2 TUT4 WNK1 TRIM24 SYNJ2 SRRM2 AFF4	5.39e-07	192	111	7	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	DCDC2 TUT4 WNK1 TRIM24 SYNJ2 SRRM2 AFF4	5.59e-07	193	111	7	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PODXL SYNE1 BLM NHSL1 AMOTL1 MARK4	4.65e-06	172	111	6	c056d44e2e130ceccadfcdceb192a7f095d779c8
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-early_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF3 MYPOP NKD2 FRMD6 TTLL11 AMOTL1	5.30e-06	176	111	6	29cda51a99100ddd2928cadc92da40f001d7e1f4
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-early_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF3 MYPOP NKD2 FRMD6 TTLL11 AMOTL1	5.30e-06	176	111	6	01774a86d7d92f31a056b753f9844f923038003e
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DCC SYCP2 SLITRK2 PIEZO2 NAV3 PLCH1	6.84e-06	184	111	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DCC SYCP2 SLITRK2 PIEZO2 NAV3 PLCH1	6.84e-06	184	111	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DCC SYCP2 SLITRK2 PIEZO2 NAV3 PLCH1	6.84e-06	184	111	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RGS12 ARHGAP6 PIEZO2 FRMD6 AGFG1 TNS3	7.97e-06	189	111	6	09dd2b3d89416192e84abe302a6237b8f3fdcb6e
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25\|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)	DENND4A TUT4 PER1 HERC1 DNMBP SRRM2	8.46e-06	191	111	6	1ecd9849d14d5ebf3daf610e83fb50820cafd3ed
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BAZ2B PODXL PIEZO2 NAV3 NAV1 SIPA1L2	8.98e-06	193	111	6	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	droplet-Lung-21m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PODXL RGS12 PIEZO2 FRMD6 AGFG1 TNS3	8.98e-06	193	111	6	3a5ad8ffad441e30a6e1bd017da7720ad57f6c57
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLG DCDC2 INHBA SYNE1 RGS12 SIPA1L2	9.80e-06	196	111	6	34e79918a448f6c19b87e1b1ce13c012b24be1f8
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLG DCDC2 INHBA SYNE1 RGS12 SIPA1L2	9.80e-06	196	111	6	8f82e01ca50aa4cd6149547505b4474a02fad618
ToppCell	Striatum-Neuronal-Excitatory\|Striatum / BrainAtlas - Mouse McCarroll V32	DCAF6 ZNF831 GRM5 NETO1 SIPA1L1 MAST3	9.80e-06	196	111	6	67400193ba469cf4d939e94f5ed94995e384bc07
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	WNK1 TRIM24 MFSD14B NAV1 KMT2A PLCH1	1.07e-05	199	111	6	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	NS-moderate-d_0-4-Epithelial\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	BAZ2B MUC16 CHST9 ZNF106 AOPEP MUC4	1.10e-05	200	111	6	64462a18afca3c1a8548a857924b8166058bf958
ToppCell	droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	E2F8 BLM CELSR2 MARK4 BMP15	6.19e-05	167	111	5	bad33497ceeab968a7eb8a48b921c6f936390743
ToppCell	Tuft-tuft-1\|World / Class top	DCAF6 ABHD18 NKD2 DMBT1 DCLK1	6.37e-05	168	111	5	8ddc2ec483ed2c6c0fb2ae521c6861ceb6d32e34
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	INHBA SIPA1L1 NAV1 DNMBP MUC4	6.73e-05	170	111	5	cc66ac6846c58be9493eb270644ee3ce0f86cfea
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	DENND4A TUT4 SYNE1 HERC1 KAT6B	6.92e-05	171	111	5	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PODXL SYNE1 PIEZO2 AMOTL1 NAV1	7.31e-05	173	111	5	afa6bb19df52541d8d17cbfac9cbdd18a5f3632d
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND4A CMTR1 HERC1 BSN MUC4	7.52e-05	174	111	5	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DCAF6 DENND4A WNK1 PICALM NAV3	7.72e-05	175	111	5	1ea6cf9da26601646f57fa14d558a5e9e1f0b345
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNE1 CHST9 GRM5 RGS12 TNS3	7.93e-05	176	111	5	327a3e81b724252e36d786de92a3ffd721ea6d7b
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma\|TCGA-Brain / Sample_Type by Project: Shred V9	SYNE1 KMT2A HERC1 KAT6B MXI1	8.15e-05	177	111	5	e8ab340b20cd41554c3841fe980e078e878af35f
ToppCell	wk_20-22-Hematologic-Meg-ery-Definitive_erythroblast\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	DENND4A TSC1 WNK1 HERC1 MXI1	9.29e-05	182	111	5	0c77ef4556c1d1512ebe9077df858b28f9e38dd5
ToppCell	droplet-Spleen-nan-18m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TUT4 BAZ2B ZNF106 SRRM2 AFF4	9.29e-05	182	111	5	eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCell	droplet-Spleen-nan-18m-Lymphocytic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TUT4 BAZ2B ZNF106 SRRM2 AFF4	9.53e-05	183	111	5	28cbf909424f3be4491d49832f0aca0386560814
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TUT4 BAZ2B ZNF106 SRRM2 AFF4	9.53e-05	183	111	5	3fa608aa6b119869ec3280dc388dfee57160e63a
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DCDC2 SYNE1 GRM5 NETO1 SIPA1L2	1.00e-04	185	111	5	34fcfd635c828dad9643bbf1c908d79282d6f5d9
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DCDC2 SYNE1 GRM5 NETO1 SIPA1L2	1.00e-04	185	111	5	8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578
ToppCell	(5)_Epithelial_cells-(5)_Glands_duct\|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	INHBA PODXL MUC16 CHST9 DMBT1	1.03e-04	186	111	5	219b1aeca17503244fabbb780bca58f22c7c0f27
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	BAZ2B MUC19 MUC16 AGFG1 NAV1	1.03e-04	186	111	5	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SYNE1 ADAMTS5 DCC PIEZO2 FRMD6	1.05e-04	187	111	5	d591a3c216997663ab77710fed0d230ffc37e41a
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SYNE1 ADAMTS5 DCC PIEZO2 FRMD6	1.05e-04	187	111	5	d1dc8c9a2c2cd10c640257161a75e7730ec5bb41
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	DCC ARHGAP6 PIEZO2 NKD2 NAV3	1.05e-04	187	111	5	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SYNE1 ADAMTS5 DCC PIEZO2 FRMD6	1.05e-04	187	111	5	ac8e092b37e042975e2ee057d3f7c6821e58e8b5
ToppCell	IPF-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	DIP2B PIKFYVE SIPA1L1 DNMBP TNS3	1.05e-04	187	111	5	af1327559f7e01bec070881cae52834917c3da65
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCAF6 CHST9 CDKL5 DCLK1 MAST3	1.14e-04	190	111	5	d594da827e3c16644952b9589cc12b947ce36279
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ABHD18 PYROXD2 MFSD14B AGFG1 MAPKBP1	1.14e-04	190	111	5	63018acb7ad80415e861643162abdc2e55968ee4
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	ARHGAP6 PIEZO2 FRMD6 NAV3 DCLK1	1.14e-04	190	111	5	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PODXL RGS12 PIEZO2 AGFG1 NAV1	1.16e-04	191	111	5	718330bb97fe8a1ffd0c82e9af23311a32eacfe1
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	INHBA PIEZO2 FRMD6 NAV3 DCLK1	1.16e-04	191	111	5	107113b930d9ad171f1b2aa20df4567c94fae7d8
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PODXL RGS12 PIEZO2 AGFG1 NAV1	1.16e-04	191	111	5	454034ad940377ee079afa8ce33f8e0bdeaf44f8
ToppCell	COVID-19_Mild-MAIT\|COVID-19_Mild / Disease condition and Cell class	ERN1 PER1 CREM GTF3C1 SIPA1L2	1.16e-04	191	111	5	e834d7a6aa7bb4f194b203d351e53bf5d95175d6
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	INHBA PIEZO2 FRMD6 NAV3 DCLK1	1.16e-04	191	111	5	bc353a79a1d11ca52bba5e3874a80d432e1a7715
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	INHBA PIEZO2 FRMD6 NAV3 DCLK1	1.19e-04	192	111	5	d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell\|Adult / Lineage, Cell type, age group and donor	ADAMTS5 FRMD6 NAV3 NAV1 DCLK1	1.19e-04	192	111	5	d21f0f577156f17c899b08871046a26b88aea011
ToppCell	Endothelial-Endothelial-B\|Endothelial / shred on cell class and cell subclass (v4)	INHBA RGS12 ARHGAP6 AGFG1 TNS3	1.19e-04	192	111	5	f8d7bd81e031d09a557722627c2f6180811cc6ab
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	ARHGAP6 ZNF106 PIEZO2 NKD2 TNS3	1.19e-04	192	111	5	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PODXL PIEZO2 MARK4 NAV3 NAV1	1.19e-04	192	111	5	c0e59e642b42c055cf73d029cf54d07d9b719359
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DIP2B DENND4A PICALM NAV3 SRRM2	1.22e-04	193	111	5	06b65110db974f4ef90d3511ff34428976a52c9c
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	BLM PIEZO2 NETO1 AMOTL1 PLCH1	1.22e-04	193	111	5	d1445b8bf2bab36e1a326ddb2a528151db016c7d
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DIP2B DENND4A PICALM NAV3 SRRM2	1.22e-04	193	111	5	9c16032bc03df8760ae199e8f19fdafa4c3f1827
ToppCell	facs-Brain_Myeloid-Hippocampus-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DIP2B DENND4A PICALM NAV3 SRRM2	1.22e-04	193	111	5	a4f91bca5eaa985982d33a528f7566ffde154d47
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	BLM PIEZO2 NETO1 AMOTL1 PLCH1	1.22e-04	193	111	5	3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PODXL SYNE1 NHSL1 PIEZO2 NAV1	1.22e-04	193	111	5	456aa8a8f1f9cbba0bd618a5f623909079c0f56b
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DIP2B DENND4A PICALM NAV3 SRRM2	1.22e-04	193	111	5	b39d7feaac4ff8f7409cd3d15e8f3c6391367275
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PODXL RGS12 PIEZO2 AGFG1 NAV1	1.25e-04	194	111	5	fc40ab57be3a15c043e3414c2c678c1dc52207c8
ToppCell	(5)_Epithelial_cells-(5)_Epi_basal\|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	INHBA CHST9 ADAMTS5 NKD2 TNS3	1.25e-04	194	111	5	b887b2ff19b76bd93c67f9a24762efae816efd45
ToppCell	moderate-Epithelial-FOXN4+\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CHST9 MUC12 E2F8 SYCP2 ALMS1	1.25e-04	194	111	5	5dffa578149104dda33774361e9e77b227b5f1ce
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DCDC2 SYNE1 CHST9 AOPEP PLCH1	1.25e-04	194	111	5	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	BLM ARHGAP6 PIEZO2 AMOTL1 PLCH1	1.25e-04	194	111	5	83863da11dfbe59b2d0a2c08db40b537c150588c
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PODXL RGS12 PIEZO2 AGFG1 NAV1	1.25e-04	194	111	5	50fa7c7940b113427c87fbdb9057fef8e1ce52c5
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PODXL RGS12 PIEZO2 AGFG1 NAV1	1.25e-04	194	111	5	8deeb3e00237e3d9ad5a1457cd0061576421b9e9
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PODXL RGS12 PIEZO2 AGFG1 NAV1	1.25e-04	194	111	5	b81801fb16e8bd0d6083fe32866051d3c60f3dc7
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PODXL NHSL1 PIEZO2 NAV3 NAV1	1.25e-04	194	111	5	e55dc30e200c9f576804acb642175eb4fa9146b5
ToppCell	IIH-mono3-\|IIH / Condition, Cell_class and T cell subcluster	INHBA CREM RGS12 ARHGAP6 NAV3	1.28e-04	195	111	5	28a858b04a7b413916c07a8d880f5ea02e985461
ToppCell	mild_COVID-19-MAIT\|mild_COVID-19 / disease group, cell group and cell class (v2)	ERN1 PER1 ZNF831 CREM GTF3C1	1.28e-04	195	111	5	b99815ec94042da1a2574468331b043d29d70b38
ToppCell	mild_COVID-19-MAIT\|World / disease group, cell group and cell class (v2)	ERN1 PER1 ZNF831 CREM GTF3C1	1.28e-04	195	111	5	74f0f709d9b3eed5d7e02a51884f02cc281782f1
ToppCell	IIH-mono3\|IIH / Condition, Cell_class and T cell subcluster	INHBA CREM RGS12 ARHGAP6 NAV3	1.28e-04	195	111	5	c6dd5af582d257be64b718e30f60220c1bf1738a
ToppCell	facs-Thymus-Thymus_Epithelium\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIEZO2 NKD2 AMOTL1 NAV3 DCLK1	1.31e-04	196	111	5	6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363
ToppCell	facs-Thymus-Thymus_Epithelium-18m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIEZO2 NKD2 AMOTL1 NAV3 DCLK1	1.31e-04	196	111	5	c8c89e469402e11aa2a9561e859b6fd1fb66c39b
ToppCell	IPF-Stromal-Myofibroblast\|World / Disease state, Lineage and Cell class	PIEZO2 NKD2 FRMD6 NAV3 DCLK1	1.31e-04	196	111	5	7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7
ToppCell	CV-Moderate-6\|CV / Virus stimulation, Condition and Cluster	WNK1 GTF3C1 KMT2A SRRM2 AFF4	1.31e-04	196	111	5	7bced0cc2112697593c478fa291b8ed3941fb811
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PODXL MARK4 NAV3 NAV1 SIPA1L2	1.31e-04	196	111	5	ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1
ToppCell	IPF-Stromal-Myofibroblast\|IPF / Disease state, Lineage and Cell class	PIEZO2 NKD2 FRMD6 NAV3 DCLK1	1.31e-04	196	111	5	2d0a48e49b3b37bb66e33e74c52915911e1f8a74
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ARHGAP6 PIEZO2 NKD2 NAV3 DCLK1	1.31e-04	196	111	5	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ARHGAP6 PIEZO2 NKD2 NAV3 DCLK1	1.31e-04	196	111	5	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	ARHGAP6 PIEZO2 FRMD6 NAV3 DCLK1	1.35e-04	197	111	5	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PODXL SYNE1 PIEZO2 NAV3 NAV1	1.38e-04	198	111	5	31ba87552be97c9b78c9e82f98e96699ccb19824
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PODXL SYNE1 NHSL1 PIEZO2 NAV1	1.38e-04	198	111	5	92416e65a0dc1a4bf931833407620ea05d362f56
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	ARHGAP6 PIEZO2 NKD2 NAV3 DCLK1	1.38e-04	198	111	5	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PYROXD2 MUC16 CHST9 SYCP2 MUC4	1.38e-04	198	111	5	af07a970afaa435c6433bb5c1cbff4c67af350c7
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	ARHGAP6 PIEZO2 NKD2 FRMD6 NAV3	1.38e-04	198	111	5	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ARHGAP6 PIEZO2 NKD2 NAV3 DCLK1	1.38e-04	198	111	5	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PODXL MUC16 CHST9 SYCP2 MUC4	1.38e-04	198	111	5	fab3135f03cf23a9f04f0eed543a9dc181f39f5f
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CHST9 SYNJ2 DMBT1 PLCH1 MUC4	1.41e-04	199	111	5	527aae1d9d37a50deefc01fc0c064a53673681bd
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	BLM ARHGAP6 PIEZO2 AMOTL1 PLCH1	1.44e-04	200	111	5	a9cdddc4e985dae59521e557479c24fcc2ac727d
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PODXL MUC16 CHST9 SYCP2 MUC4	1.44e-04	200	111	5	b992eeddee38e6fe3564e9b1850f6b20b89bf47d
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5\|Neuronal / cells hierarchy compared to all cells using T-Statistic	BLM ARHGAP6 PIEZO2 AMOTL1 PLCH1	1.44e-04	200	111	5	33b9199e0dfc267e2cea20b82d1c167f8adcc635
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB--L2-4\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ADAMTS5 BLM PIEZO2 AMOTL1 PLCH1	1.44e-04	200	111	5	5ec469267747dce3601c1d8ad01af89fa5b29acc
ToppCell	Neuronal-Excitatory-eA(LAMP5_LINC00507)-LTK---L2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	INHBA RGS12 SYNJ2 SIPA1L1 MAST3	1.44e-04	200	111	5	6ebdae4438bc64c6620416f64a7e22fbca2664bf
ToppCell	Neuronal-Excitatory-eA(LAMP5_LINC00507)-LTK-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	INHBA RGS12 SYNJ2 SIPA1L1 MAST3	1.44e-04	200	111	5	081ca331b56f85167acfc73af9d2e91f398f8c4d
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ADAMTS5 BLM PIEZO2 AMOTL1 PLCH1	1.44e-04	200	111	5	e79d93d55b25804f2608185168da472301b6ebca
ToppCell	Neuronal-Excitatory-eA(LAMP5_LINC00507)-LTK--\|Neuronal / cells hierarchy compared to all cells using T-Statistic	INHBA RGS12 SYNJ2 SIPA1L1 MAST3	1.44e-04	200	111	5	66e2f3e2e9063f17b47621120eb6009405f69e7e
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGAP6 PIEZO2 NKD2 NAV3 DCLK1	1.44e-04	200	111	5	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SYNE1 ARHGAP6 NKD2 NAV3 DCLK1	1.44e-04	200	111	5	3dd022e974fec7013ba18f333da63f58fbf2dd7c
Computational	Genes in the cancer module 418.	BAZ2B RALGAPB NHSL1 NKD2 MXI1	3.64e-05	60	68	5	MODULE_418
Computational	Genes in the cancer module 455.	RALGAPB NHSL1 NKD2 MXI1	1.02e-04	39	68	4	MODULE_455
Drug	Tolfenamic acid [13710-19-5]; Down 200; 15.2uM; HL60; HG-U133A	TCF3 KRT10 DENND4A PSTPIP1 TRIM24 CCNT2 MARK4 KMT2A	4.69e-06	194	110	8	1437_DN
Drug	alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A	TCF3 ABHD18 WNK1 CCNT2 CABYR NFRKB UGGT2 MAPKBP1	5.25e-06	197	110	8	1635_DN
Drug	Cefuroxime sodium salt [56238-63-2]; Down 200; 9uM; MCF7; HT_HG-U133A	TCF3 ABHD18 IQSEC2 RGS12 SYNJ2 NFRKB PLCH1 MAST3	5.66e-06	199	110	8	6088_DN
Drug	resveratrol; Down 200; 10uM; MCF7; HT_HG-U133A_EA	TCF3 MARCHF7 E2F8 MARK4 NFRKB AGFG1 TNS3	2.47e-05	177	110	7	841_DN
Drug	0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A	CREM ADCY9 E2F8 BLM ALMS1 SYNJ2 PLCH1	3.28e-05	185	110	7	4755_DN
Drug	Apigenin [520-36-5]; Down 200; 14.8uM; MCF7; HT_HG-U133A	BAZ2B CREM E2F8 DENND1B ALMS1 AGFG1 BRWD1	3.64e-05	188	110	7	3257_DN
Drug	Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A	PIKFYVE ZNF106 SYCP2 ALMS1 HERC1 MAST3 BRWD1	4.02e-05	191	110	7	4168_DN
Drug	Cyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A	ABHD18 WNK1 RGS12 ALMS1 SYNJ2 SIPA1L1 KAT6B	4.16e-05	192	110	7	3252_DN
Drug	Promethazine hydrochloride [58-33-3]; Down 200; 12.4uM; HL60; HT_HG-U133A	TCF3 CMTR1 INHBA APC PHKA2 GTF3C1 CAMSAP2	4.30e-05	193	110	7	3100_DN
Drug	Terconazole [67915-31-5]; Up 200; 7.6uM; PC3; HT_HG-U133A	APC CREM ADCY9 NFRKB NAV3 AFF4 BRWD1	4.30e-05	193	110	7	4583_UP
Drug	(-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A	ABHD18 APC WNK1 PHKA2 MARK4 MAPKBP1 PLCH1	4.44e-05	194	110	7	3539_DN
Drug	ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A	TCF3 WNK1 E2F8 ALMS1 AGFG1 KMT2A BRWD1	4.59e-05	195	110	7	6918_UP
Drug	N6-methyladenosine [1867-73-8]; Up 200; 14.2uM; HL60; HT_HG-U133A	TCF3 APC SYNJ2 SIPA1L1 DEPDC5 DNMBP CAMSAP2	4.59e-05	195	110	7	1271_UP
Drug	Methacycline hydrochloride [3963-95-9]; Down 200; 8.4uM; HL60; HT_HG-U133A	SYNE1 PER1 ADCY9 MARK4 KAT6B DNMBP CAMSAP2	4.59e-05	195	110	7	2901_DN
Drug	(1)-Nipecotic acid [498-95-3]; Down 200; 31uM; HL60; HT_HG-U133A	SYNE1 PER1 CELSR2 MARK4 DNMBP CAMSAP2 BRWD1	4.74e-05	196	110	7	3121_DN
Drug	Cefaclor [70356-03-5]; Down 200; 10.4uM; MCF7; HT_HG-U133A	TCF3 PER1 APC CREM SYNJ2 MARK4 PLCH1	4.74e-05	196	110	7	2843_DN
Drug	Domperidone maleate; Down 200; 7.4uM; HL60; HT_HG-U133A	SYNE1 PER1 STIM1 NFRKB KMT2A MAPKBP1 KAT6B	4.74e-05	196	110	7	1301_DN
Drug	Cefoperazone dihydrate; Down 200; 5.8uM; PC3; HT_HG-U133A	DENND4A IQSEC2 APC STIM1 SIPA1L1 MARK4 PLCH1	4.74e-05	196	110	7	6323_DN
Drug	Riluzole hydrochloride; Up 200; 14.8uM; HL60; HT_HG-U133A	INHBA WNK1 CREM SYNJ2 MARK4 KMT2A SRRM2	4.90e-05	197	110	7	2334_UP
Drug	Nicardipine hydrochloride [54527-84-3]; Down 200; 7.8uM; MCF7; HT_HG-U133A	ABHD18 APC WNK1 RGS12 CCNT2 SYNJ2 KMT2A	4.90e-05	197	110	7	5397_DN
Drug	Nomegestrol acetate [58652-20-3]; Up 200; 10.8uM; PC3; HT_HG-U133A	PER1 WNK1 CREM ARHGAP6 CELSR2 PLCH1 BRWD1	5.05e-05	198	110	7	6362_UP
Drug	Isocorydine (+) [475-67-2]; Up 200; 11.8uM; HL60; HG-U133A	ABHD18 IQSEC2 PICALM CREM NFRKB DMBT1 BMP15	5.05e-05	198	110	7	1787_UP
Drug	Aspartic acid, N-acetyl (R,S) [997-55-7]; Down 200; 22.8uM; HL60; HT_HG-U133A	TCF3 RALGAPB WNK1 PHKA2 KMT2A KAT6B CAMSAP2	5.05e-05	198	110	7	1329_DN
Drug	Neostigmine bromide [114-80-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A	CREM CCNT2 SYCP2 ALMS1 SYNJ2 SIPA1L1 AFF4	5.05e-05	198	110	7	5335_DN
Drug	Azathioprine [446-86-6]; Down 200; 14.4uM; HL60; HG-U133A	KRT10 RALGAPB PHKA2 MARK4 RBM15B AGFG1 MAPKBP1	5.22e-05	199	110	7	2028_DN
Drug	Karakoline [39089-30-0]; Down 200; 10.6uM; PC3; HT_HG-U133A	TCF3 ABHD18 SYNE1 APC ADCY9 DMBT1 MAST3	5.22e-05	199	110	7	4297_DN
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A	TUT4 IQSEC2 APC RGS12 PHKA2 PLCH1 SRRM2	5.22e-05	199	110	7	5219_UP
Drug	Sisomicin sulfate [53179-09-2]; Down 200; 2.8uM; PC3; HT_HG-U133A	PER1 APC PHKA2 CABYR SYNJ2 PLCH1 BMP15	5.39e-05	200	110	7	4014_DN
Drug	Aminophylline [317-34-0]; Down 200; 9.6uM; HL60; HT_HG-U133A	INHBA PER1 APC ADAMTS5 CELSR2 SIPA1L1 PLCH1	5.39e-05	200	110	7	3036_DN
Drug	2,4,6-trimethylpyrylium	NETO1 KAT6B	6.92e-05	3	110	2	CID000135854
Drug	Digoxigenin [1672-46-4]; Up 200; 10.2uM; PC3; HT_HG-U133A	PER1 ADCY9 CCNT2 KMT2A DMBT1 AFF4	1.79e-04	170	110	6	4680_UP
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	KIAA0232 TRIM24 PIKFYVE KAT6B CAMSAP2 BRWD1	2.59e-04	182	110	6	3887_DN
Drug	0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A	BAZ2B E2F8 ALMS1 SYNJ2 RBM15B AGFG1	2.59e-04	182	110	6	3630_DN
Drug	Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	TCF3 BAZ2B ADCY9 E2F8 PLCH1 KAT6B	2.66e-04	183	110	6	5613_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA	E2F8 SYNJ2 AOPEP MARK4 NFRKB KAT6B	2.91e-04	186	110	6	831_DN
Drug	Dicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; PC3; HT_HG-U133A	CREM RGS12 NFRKB NAV3 DMBT1 AFF4	2.99e-04	187	110	6	4581_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	WNK1 SYNJ2 AGFG1 KMT2A KAT6B SRRM2	2.99e-04	187	110	6	4302_DN
Drug	0179445-0000 [211246-22-9]; Down 200; 10uM; PC3; HT_HG-U133A	DENND4A E2F8 ARHGAP6 ALMS1 MARK4 RBM15B	3.17e-04	189	110	6	3733_DN
Drug	Corticosterone [50-22-6]; Up 200; 11.6uM; HL60; HT_HG-U133A	TUT4 CMTR1 PER1 APC CREM CAMSAP2	3.17e-04	189	110	6	1307_UP
Drug	Muramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; PC3; HT_HG-U133A	ABHD18 APC WNK1 SYNJ2 MARK4 PLCH1	3.26e-04	190	110	6	4582_DN
Drug	Fluvoxamine maleate [61718-82-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A	APC WNK1 KMT2A KAT6B CAMSAP2 BMP15	3.26e-04	190	110	6	4114_DN
Drug	Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A	ABHD18 APC WNK1 ALMS1 AGFG1 KAT6B	3.35e-04	191	110	6	4283_DN
Drug	carmustine; Up 200; 100uM; MCF7; HT_HG-U133A	MARCHF7 CREM PIKFYVE MAPKBP1 CAMSAP2 BRWD1	3.44e-04	192	110	6	6914_UP
Drug	ICI 182,780; Down 200; 0.01uM; PC3; HT_HG-U133A	TCF3 IQSEC2 APC CREM ADCY9 MARK4	3.44e-04	192	110	6	4462_DN
Drug	estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A	TUT4 APC ADCY9 PHKA2 CABYR ALMS1	3.44e-04	192	110	6	5238_UP
Drug	Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; MCF7; HT_HG-U133A	ABHD18 PER1 APC WNK1 ALMS1 MARK4	3.44e-04	192	110	6	2292_DN
Drug	Naphazoline hydrochloride [550-99-2]; Down 200; 16.2uM; PC3; HT_HG-U133A	ABHD18 SYNJ2 NAV3 AGFG1 KMT2A SRRM2	3.54e-04	193	110	6	6604_DN
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A	ABHD18 WNK1 RGS12 PHKA2 ALMS1 MAPKBP1	3.54e-04	193	110	6	3258_DN
Drug	geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A_EA	BLM CCNT2 SYNJ2 AOPEP MARK4 MAPKBP1	3.54e-04	193	110	6	864_DN
Drug	Haloperidol [52-86-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A	ABHD18 WNK1 RGS12 STIM1 ALMS1 KAT6B	3.54e-04	193	110	6	5273_DN
Drug	Hymecromone [90-33-5]; Down 200; 22.8uM; PC3; HT_HG-U133A	IQSEC2 APC MARCHF7 CREM SYNJ2 PLCH1	3.54e-04	193	110	6	4623_DN
Drug	aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A	ABHD18 KIAA0232 CREM PHKA2 CCNT2 SYNJ2	3.54e-04	193	110	6	6964_DN
Drug	haloperidol; Down 200; 10uM; HL60; HT_HG-U133A	TCF3 APC CCNT2 ALMS1 MAPKBP1 BRWD1	3.64e-04	194	110	6	1185_DN
Drug	Flumethasone [2135-17-3]; Down 200; 9.8uM; PC3; HT_HG-U133A	KRT10 MARCHF7 WNK1 SYNJ2 NAV3 AGFG1	3.64e-04	194	110	6	4272_DN
Drug	Nystatine [1400-61-9]; Up 200; 4.4uM; PC3; HT_HG-U133A	IQSEC2 APC MUC16 WNK1 STIM1 KMT2A	3.64e-04	194	110	6	4223_UP
Drug	Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A	TCF3 ABHD18 PIKFYVE ALMS1 AGFG1 MAPKBP1	3.74e-04	195	110	6	7444_DN
Drug	troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A	TCF3 DENND4A PER1 CCNT2 NFRKB MAST3	3.74e-04	195	110	6	1657_DN
Drug	Mefenamic acid [61-68-7]; Down 200; 16.6uM; PC3; HT_HG-U133A	DENND4A WNK1 CREM ALMS1 AGFG1 PLCH1	3.74e-04	195	110	6	5109_DN
Drug	Cefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; PC3; HT_HG-U133A	STIM1 SYNJ2 MARK4 NAV3 DNMBP BRWD1	3.74e-04	195	110	6	7394_DN
Drug	Luteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A	RALGAPB APC CABYR AOPEP NFRKB PLCH1	3.74e-04	195	110	6	5004_DN
Drug	Thioguanosine [85-31-4]; Down 200; 12.6uM; PC3; HT_HG-U133A	WNK1 CABYR AGFG1 KAT6B DNMBP BRWD1	3.74e-04	195	110	6	6643_DN
Drug	Alfaxalone [23930-19-0]; Down 200; 12uM; MCF7; HT_HG-U133A	APC CREM STIM1 SYCP2 SYNJ2 MAST3	3.74e-04	195	110	6	6514_DN
Drug	Lobelanidine hydrochloride [6112-86-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A	TCF3 INHBA ADAMTS5 RGS12 DMBT1 SRRM2	3.74e-04	195	110	6	2897_UP
Drug	Azacyclonol [115-46-8]; Down 200; 15uM; MCF7; HT_HG-U133A	KIAA0232 RGS12 PHKA2 ALMS1 MARK4 MAPKBP1	3.74e-04	195	110	6	1520_DN
Drug	Cyclobenzaprine hydrochloride [6202-23-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A	TUT4 PER1 APC CCNT2 NFRKB KMT2A	3.74e-04	195	110	6	3268_UP
Drug	Triamcinolone [124-94-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A	APC RGS12 PHKA2 SYNJ2 MARK4 UGGT2	3.74e-04	195	110	6	2241_DN
Drug	Ethionamide [536-33-4]; Up 200; 24uM; PC3; HT_HG-U133A	SYNE1 IQSEC2 APC CREM STIM1 AFF4	3.74e-04	195	110	6	4593_UP
Drug	Cephalexin monohydrate [23325-78-2]; Up 200; 11uM; HL60; HT_HG-U133A	TCF3 INHBA CCNT2 GTF3C1 SYNJ2 KMT2A	3.74e-04	195	110	6	1273_UP
Drug	Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; PC3; HT_HG-U133A	PHKA2 ALMS1 NAV3 KMT2A BMP15 BRWD1	3.74e-04	195	110	6	2071_DN
Drug	radicicol; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	TCF3 ADCY9 ALMS1 AOPEP KMT2A AFF4	3.74e-04	195	110	6	953_DN
Drug	Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; HL60; HT_HG-U133A	TCF3 ABHD18 CCNT2 ALMS1 MAPKBP1 CAMSAP2	3.84e-04	196	110	6	6155_DN
Drug	Debrisoquin sulfate [581-88-4]; Up 200; 9uM; MCF7; HT_HG-U133A	PODXL WNK1 ADCY9 SYNJ2 KAT6B SRRM2	3.84e-04	196	110	6	5288_UP
Drug	Tolazamide [1156-19-0]; Down 200; 12.8uM; PC3; HT_HG-U133A	APC CREM STIM1 ALMS1 AFF4 BMP15	3.84e-04	196	110	6	4003_DN
Drug	Etidronic acid, disodium salt [7414-83-7]; Up 200; 16uM; PC3; HT_HG-U133A	APC ADAMTS5 RGS12 ADCY9 NAV3 AFF4	3.84e-04	196	110	6	4564_UP
Drug	Benzbromarone [3562-84-3]; Down 200; 9.4uM; PC3; HT_HG-U133A	PER1 APC TSC1 NAV3 PLCH1 SRRM2	3.84e-04	196	110	6	6669_DN
Drug	Thiamphenicol [15318-45-3]; Up 200; 11.2uM; HL60; HT_HG-U133A	INHBA APC PHKA2 KMT2A CAMSAP2 BRWD1	3.84e-04	196	110	6	1867_UP
Drug	Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; MCF7; HT_HG-U133A	WNK1 SYCP2 SYNJ2 SIPA1L1 MARK4 MAPKBP1	3.95e-04	197	110	6	5436_DN
Drug	Sulfamerazine [127-79-7]; Up 200; 15.2uM; HL60; HT_HG-U133A	CMTR1 ADAMTS5 RGS12 SIPA1L1 NFRKB KMT2A	3.95e-04	197	110	6	2181_UP
Drug	PHA-00767505E [723337-45-9]; Down 200; 10uM; PC3; HT_HG-U133A	PHKA2 SYCP2 MARK4 PLCH1 AFF4 BMP15	3.95e-04	197	110	6	6545_DN
Drug	Cyclacillin [3485-14-1]; Down 200; 11.8uM; PC3; HT_HG-U133A	TCF3 SYNE1 PER1 APC ADCY9 SYCP2	3.95e-04	197	110	6	3800_DN
Drug	Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A	IQSEC2 APC WNK1 ALMS1 SYNJ2 MAST3	3.95e-04	197	110	6	3885_DN
Drug	Gliquidone [33342-05-1]; Down 200; 7.6uM; HL60; HT_HG-U133A	IQSEC2 ADCY9 PHKA2 GTF3C1 ALMS1 DNMBP	3.95e-04	197	110	6	3126_DN
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; MCF7; HT_HG-U133A	INHBA IQSEC2 PSTPIP1 RGS12 MARK4 KMT2A	3.95e-04	197	110	6	3639_UP
Drug	Benzocaine [94-09-7]; Down 200; 24.2uM; MCF7; HT_HG-U133A	SYNE1 SIPA1L1 MARK4 MAPKBP1 SRRM2 MAST3	3.95e-04	197	110	6	2822_DN
Drug	Mephenesin [59-47-2]; Down 200; 22uM; MCF7; HT_HG-U133A	TCF3 BAZ2B PER1 CCNT2 SYNJ2 MARK4	3.95e-04	197	110	6	2304_DN
Drug	Meglumine [6284-40-8]; Down 200; 20.4uM; HL60; HT_HG-U133A	INHBA PER1 CCNT2 KMT2A KAT6B DNMBP	3.95e-04	197	110	6	3068_DN
Drug	LY 294002; Down 200; 0.1uM; HL60; HT_HG-U133A	APC STIM1 ALMS1 MARK4 NFRKB MAST3	3.95e-04	197	110	6	1157_DN
Drug	Isometheptene mucate; Down 200; 8.2uM; HL60; HT_HG-U133A	INHBA SYNE1 IQSEC2 CREM MARK4 CAMSAP2	3.95e-04	197	110	6	3145_DN
Drug	Rilmenidine hemifumarate [54187-04-1]; Down 200; 8.4uM; HL60; HT_HG-U133A	INHBA APC ADAMTS5 AOPEP MAST3 BMP15	3.95e-04	197	110	6	3133_DN
Drug	ICI 182,780; Down 200; 1uM; PC3; HG-U133A	ERN1 WNK1 ALMS1 AGFG1 DMBT1 MAPKBP1	3.95e-04	197	110	6	704_DN
Drug	Ramipril [87333-19-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A	ABHD18 ADCY9 ALMS1 SYNJ2 UGGT2 KAT6B	3.95e-04	197	110	6	6792_DN
Drug	Ethamivan [304-84-7]; Up 200; 18uM; MCF7; HT_HG-U133A	RGS12 ALMS1 SYNJ2 SIPA1L1 PLCH1 MUC4	3.95e-04	197	110	6	7021_UP
Drug	Morantel tartrate [26155-31-7]; Down 200; 10.8uM; PC3; HT_HG-U133A	PER1 ALMS1 DMBT1 HERC1 SRRM2 BRWD1	3.95e-04	197	110	6	1798_DN
Drug	prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A	WNK1 PHKA2 CCNT2 KAT6B SRRM2 MAST3	3.95e-04	197	110	6	1640_DN
Drug	Meclocycline sulfosalicylate [73816-42-9]; Down 200; 5.8uM; MCF7; HT_HG-U133A	APC WNK1 RGS12 STIM1 ALMS1 SRRM2	3.95e-04	197	110	6	3277_DN
Drug	Chlormezanone [80-77-3]; Down 200; 14.6uM; MCF7; HT_HG-U133A	INHBA WNK1 SIPA1L1 NFRKB PLCH1 BMP15	3.95e-04	197	110	6	5697_DN
Drug	Tiletamine hydrochloride; Up 200; 15.4uM; PC3; HT_HG-U133A	SYNE1 STIM1 ARHGAP6 PLCH1 SRRM2 BRWD1	3.95e-04	197	110	6	7311_UP
Drug	Lymecycline [992-21-2]; Down 200; 6.6uM; MCF7; HT_HG-U133A	ABHD18 WNK1 RGS12 STIM1 SYNJ2 MARK4	3.95e-04	197	110	6	3514_DN
Drug	Tobramycin [32986-56-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A	ERN1 INHBA WNK1 NFRKB DMBT1 PLCH1	4.06e-04	198	110	6	2841_UP
Drug	Hydroflumethiazide [135-09-1]; Up 200; 12uM; HL60; HT_HG-U133A	TCF3 APC WNK1 NFRKB DNMBP BMP15	4.06e-04	198	110	6	1851_UP
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Positive	PER1 CREM STIM1 AOPEP SIPA1L1 KAT6B	8.54e-06	131	107	6	C4704862
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Negative	PER1 CREM STIM1 AOPEP SIPA1L1 KAT6B	8.54e-06	131	107	6	C4552091
Disease	Juvenile arthritis	PER1 CREM STIM1 AOPEP SIPA1L1 KAT6B	8.54e-06	131	107	6	C3495559
Disease	Juvenile psoriatic arthritis	PER1 CREM STIM1 AOPEP SIPA1L1 KAT6B	8.54e-06	131	107	6	C3714758
Disease	Juvenile-Onset Still Disease	PER1 CREM STIM1 AOPEP SIPA1L1 KAT6B	1.02e-05	135	107	6	C0087031
Disease	X-12093 measurement	PYROXD2 ALMS1	3.90e-05	3	107	2	EFO_0021285
Disease	Ovarian Serous Adenocarcinoma	ERN1 TRIM24 CDKL5	7.79e-05	23	107	3	C1335177
Disease	urate measurement, bone density	BAZ2B PODXL SYNE1 MARCHF7 MARK4 NAV1 UGGT2 DMBT1 KAT6B DCLK1	8.70e-05	619	107	10	EFO_0003923, EFO_0004531
Disease	cortical surface area measurement	BAZ2B PODXL APC MARCHF7 PSTPIP1 PICALM NHSL1 ZNF106 DENND1B AOPEP NAV3 AGFG1 LINC00574 NAV1 DCLK1	1.03e-04	1345	107	15	EFO_0010736
Disease	obsolete_red blood cell distribution width	DIP2B BAZ2B KIAA0232 WNK1 PICALM ZBTB24 ADCY9 DENND1B NKD2 MFSD14B MARK4 NFRKB HERC1 MUC4 MAST3	1.05e-04	1347	107	15	EFO_0005192
Disease	N2-acetyl,N6-methyllysine measurement	PYROXD2 ALMS1	1.29e-04	5	107	2	EFO_0800109
Disease	neuroticism measurement, cognitive function measurement	APC DCC GRM5 DENND1B GTF3C1 SIPA1L1 TTLL11 NAV1 MAST3	2.24e-04	566	107	9	EFO_0007660, EFO_0008354
Disease	Epilepsy, Cryptogenic	ERN1 IQSEC2 TSC1 CDKL5	2.30e-04	82	107	4	C0086237
Disease	Awakening Epilepsy	ERN1 IQSEC2 TSC1 CDKL5	2.30e-04	82	107	4	C0751111
Disease	Aura	ERN1 IQSEC2 TSC1 CDKL5	2.30e-04	82	107	4	C0236018
Disease	Colorectal Carcinoma	TCF3 SYNE1 PER1 APC DCC WNK1 CDKL5 CABYR CAMSAP2 DCLK1	2.41e-04	702	107	10	C0009402
Disease	N2,N2-dimethylguanosine measurement	PYROXD2 ALMS1	3.60e-04	8	107	2	EFO_0021125
Disease	parental longevity	PODXL DCC GRM5 RGS12 DENND1B CELSR2 MARK4 BSN	4.47e-04	494	107	8	EFO_0007796
Disease	hepatocyte growth factor measurement	RGS12 CAMSAP2 BRWD1	5.51e-04	44	107	3	EFO_0006903
Disease	Epilepsy	ERN1 IQSEC2 TSC1 CDKL5	6.79e-04	109	107	4	C0014544
Disease	testosterone measurement	DIP2B DENND4A INHBA IQSEC2 ADCY9 ARHGAP6 MYPOP DENND1B AOPEP DNMBP TNS3 MXI1 BRWD1	7.20e-04	1275	107	13	EFO_0004908
Disease	intelligence, self reported educational attainment	DENND4A DCC TTLL11 BSN	8.85e-04	117	107	4	EFO_0004337, EFO_0004784
Disease	colorectal cancer (is_implicated_in)	TCF3 APC DCC STIM1	1.00e-03	121	107	4	DOID:9256 (is_implicated_in)
Disease	alcohol dependence measurement	PODXL TNS3 KLB	1.06e-03	55	107	3	EFO_0007835
Disease	insomnia measurement	MARCHF7 DCC GRM5 ALMS1 NAV1 KMT2A PLCH1	1.18e-03	443	107	7	EFO_0007876
Disease	unipolar depression, cognitive function measurement	DCAF6 ADAMTS5	1.33e-03	15	107	2	EFO_0003761, EFO_0008354
Disease	hepcidin:transferrin saturation ratio	MUC16 SLITRK1	1.33e-03	15	107	2	EFO_0007902
Disease	cardiovascular disease	ZNF831 ADCY9 CELSR2 OR10AD1 NAV1 SIPA1L2 MXI1	1.41e-03	457	107	7	EFO_0000319
Disease	Precursor Cell Lymphoblastic Leukemia Lymphoma	TCF3 BLM KMT2A	1.43e-03	61	107	3	C1961102
Disease	immature granulocyte count	MARK4 DEPDC5	1.71e-03	17	107	2	EFO_0803542
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	DIP2B SRRM2	1.71e-03	17	107	2	DOID:0060307 (is_implicated_in)
Disease	platelet component distribution width	SYNE1 KIAA0232 ZNF831 WNK1 STIM1 SYNJ2 MARK4 HERC1 BRWD1	1.73e-03	755	107	9	EFO_0007984
Disease	glucuronate measurement	CHST9 DCLK1	1.92e-03	18	107	2	EFO_0010486
Disease	Febrile seizure (within the age range of 3 months to 6 years)	HERC1 BSN	1.92e-03	18	107	2	HP_0002373
Disease	physical activity measurement	APC GRM5 RGS12 SIPA1L1 HERC1	2.03e-03	245	107	5	EFO_0008002
Disease	Alzheimer disease, educational attainment	DENND4A DCC TTLL11 MARK4 BSN	2.10e-03	247	107	5	EFO_0011015, MONDO_0004975
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	ERN1 TSC1 NAV3 MUC4	2.10e-03	148	107	4	C0279702
Disease	event free survival time, urinary bladder cancer	DCC DCLK1	2.14e-03	19	107	2	EFO_0000482, MONDO_0001187
Disease	unipolar depression, bipolar disorder	SYNE1 DCC GRM5 DENND1B	2.54e-03	156	107	4	EFO_0003761, MONDO_0004985
Disease	Precursor B-cell lymphoblastic leukemia	TCF3 KMT2A	2.62e-03	21	107	2	C1292769
Disease	Sjogren's syndrome (is_marker_for)	MUC19 MUC16	3.41e-03	24	107	2	DOID:12894 (is_marker_for)
Disease	West Syndrome	TSC1 CDKL5	3.41e-03	24	107	2	C0037769
Disease	Colorectal Neoplasms	SYNE1 APC DCC CABYR DCLK1	3.43e-03	277	107	5	C0009404

Protein segments in the cluster

Peptide	Gene	Start	Entry
SSERHSSSDEGSGKS	CCNT2	531	O60583
SVTSHGSNKVGSHTS	ADAMTS5	861	Q9UNA0
NHDSSSFHSRTSGKS	BAZ2B	146	Q9UIF8
HNSSKTSVSATSEGL	ABHD18	281	Q0P651
SKSDTTVESSHSGSN	ALMS1	3291	Q8TCU4
SIASTTAASSAHAKT	AMOTL1	856	Q8IY63
TAASSAHAKTGSKDS	AMOTL1	861	Q8IY63
AHAKTGSKDSSTQTD	AMOTL1	866	Q8IY63
SHSDASVGSHSSTES	DNMBP	1351	Q6XZF7
SVGSHSSTESEHGSS	DNMBP	1356	Q6XZF7
AEAVHSGTSVKSSSG	CABYR	456	O75952
SKDKTGHTSDSGASV	AOPEP	556	Q8N6M6
DSAGSLHSTSRSGKS	CELSR2	2661	Q9HCU4
SIASSSRGIGSHCKS	DCAF6	501	Q58WW2
DSSTAKEHGHFSSLS	FLG	3921	P20930
KGQHGSEHSKSRSSS	AFF4	166	Q9UHB7
SHIAGTSGSSLSFHS	INHBA	356	P08476
SADGKSDSSKTIHTN	DENND4A	296	Q7Z401
KESSSNSLSNSRHGA	RBM15B	646	Q8NDT2
HHCGSQLSSTKGSRS	NETO1	431	Q8TDF5
HLESDGKSSTSSDSG	PGBD4	56	Q96DM1
SGHAASGKDSSSRLA	KAT6B	386	Q8WYB5
VHGGKSSAQSAESSS	DEPDC5	1061	O75140
HHSTSGKETEGTLNT	MUC16	421	Q8WXI7
TTDSLDLSHGVHTSS	MUC16	1841	Q8WXI7
STFSLAHGLKGTSTS	MUC16	6651	Q8WXI7
LSGTHSTMSQGLSHS	MUC16	9686	Q8WXI7
SSTATSHGADVSSAI	MUC16	10626	Q8WXI7
STGHATALHDTDASS	MUC4	2106	Q99102
HGSPKTTSLAASAAS	PSTPIP1	316	O43586
TNSGGKSSHSVTTDL	PODXL	156	O00592
TQLGSKSTSHSGQDT	DCC	1196	P43146
SESSDSEVHSGGSHT	FLG2	1881	Q5D862
SSSGRGKTFSTCASH	OR10AD1	231	Q8NGE0
GGSSKALSTLSAHST	OR4F21	231	O95013
HKSSSSGSVGESSSK	KRT10	566	P13645
HVGDGKSSSAASRSS	GRM5	846	P41594
ASHLQQGTASGSSKA	NFRKB	1266	Q6P4R8
GQASASSSSASSTHH	IQSEC2	1226	Q5JU85
KQGHHSSSDSSSSSS	IMUP	46	Q9GZP8
SSSKGSDGHTLAFTT	HERC1	461	Q15751
HSDSGSDSKHDATAS	BSN	2636	Q9UPA5
GISAEVTASSSKHSG	BMP15	271	O95972
SSQHGGSSTSLASTK	DCLK1	346	O15075
LHSESSSLSESGASH	CCDC120	211	Q96HB5
SAGQRESKSSGSSHA	NHSL1	436	Q5SYE7
TAHSPKDGSSVHSTT	IRF2BPL	636	Q9H1B7
HSSSSGNGKDSALLE	PER1	71	O15534
KAERNIHTGSSSSSS	KIAA0232	341	Q92628
SGSSKALSTLTAHIT	OR4K1	231	Q8NGD4
GGSSKALSTCSAHFT	OR4K3	231	Q96R72
KFSGTTISSGGSHTE	MUC19	6376	Q7Z5P9
SHSSIGSGNDADSKK	NAV3	1681	Q8IVL0
SSASSTLSHGEVKGT	DIP2B	186	Q9P265
DASVNHSSGSSKTLR	NKD2	156	Q969F2
SFSVGGRHSSTDSNK	ARHGAP6	646	O43182
AHSKDASSTSSGQSG	PIKFYVE	1171	Q9Y2I7
TASHSSSHTSGIEAD	FRMD6	386	Q96NE9
GSILKHSSFSVSTDS	ATMIN	721	O43313
IIGSSSASHTSQATS	BLM	1376	P54132
SASHTSQATSGANSK	BLM	1381	P54132
TTHSSKATGSKDSTD	E2F8	546	A0AVK6
RASNHSLCSGSSASK	ERN1	531	O75460
KSHSSADAGVSLVSG	LINC00574	26	Q9H8X3
SDSGSTGEHTKSLVT	SLC3A2	406	P08195
TSLGSDSSTQAKDAH	ADCY9	1291	O60503
SSSVTSSGEDSKSHI	BRWD1	2046	Q9NSI6
GLSSLSHNHSSESDS	MARCHF7	356	Q9H992
SDTTNGTSSSKGTSH	MARK4	391	Q96L34
SFSSGLHHSLSSSES	MAST3	1091	O60307
HSSSITAVKFAASDG	MAPKBP1	566	O60336
THLKNVSSTNGSSDS	KLB	116	Q86Z14
CGSSEKSSAASQHSS	KMT2A	456	Q03164
AKSHGALSDSKSVSN	CDKL5	486	O76039
DGSITASLTESKSAH	CREM	11	Q03060
TSHASTAGSESSLAL	DMBT1	1366	Q9UGM3
STHSSDQGKLAAAKS	DENND1B	576	Q6P3S1
RKLNHTDGKSSGSSS	CAMSAP2	706	Q08AD1
DRHSKSTVGSSDNSS	DCDC2	256	Q9UHG0
SGVQKHSNSSSGSLT	MFSD14B	456	Q5SR56
HGAKASTTSLSGSDS	CMTR1	41	Q8N1G2
FSVGQAASSSAHSSK	PHKA2	1021	P46019
GGSSKALSTLSAHST	OR4F3;	231	Q6IEY1
VHGSVLSLASSASST	NAV1	1056	Q8NEY1
ITSHSSIGSSKDADA	NAV1	1191	Q8NEY1
SAAAKTHTTALAGRS	SRRM2	281	Q9UQ35
HSRSTKGGSDSSLSE	SYNE1	8716	Q8NF91
KSASDASISSGTHGQ	SYNJ2	1121	O15056
GSSVKLTCTLSSGHS	IGLV4-60	36	A0A075B6I1
HSSSGDTFSLKTAHS	NPHP3	1306	Q7Z494
SSGATHSSRKGAIAS	OR7G3	261	Q8NG95
KSASDSSQRGSHADT	SLITRK2	266	Q9H156
SLSLDIHSKSQAGST	SIPA1L1	1391	O43166
GDKSCSSHSSSNTLS	SIPA1L2	1216	Q9P2F8
TLSVSSDSGHSTASA	TNS3	386	Q68CZ2
SDSGHSTASARTDKT	TNS3	391	Q68CZ2
SHSEKATGTSSGANS	STIM1	26	Q13586
VASVHASISGSSASS	AGFG1	136	P52594
SFSKSSSGQSSKTEH	APC	1196	P25054
SSSKHSSPSGTVAAR	APC	2766	P25054
TSHSQGGDQALSKST	CHST9	111	Q7L1S5
TAAQHSVTGSAVSKT	PICALM	11	Q13492
SSGSSSKPAGADSTH	TRIM24	696	O15164
SGNFIHSDSASTGSK	TTLL11	441	Q8NHH1
QRKTHSAASSSQGAS	TSC1	516	Q92574
PASKHSLGSDHSSVS	RGS12	851	O14924
SHSKNSTGLAETGTH	SLITRK1	591	Q96PX8
SEGTHFTESHSSLSS	TCF3	76	P15923
SDAIASSATTHGASI	PYROXD2	291	Q8N2H3
SSSISDHNSEGTGKV	SYCP2	656	Q9BX26
FGKHSAAADITSSLS	PIEZO2	2211	Q9H5I5
LASERSGGSLSTKSH	ZBED10P	176	Q96FA7
NLKSHSRTNSGISSA	RALGAPB	711	Q86X10
SSSSSALLHKDTSQG	PLCH1	1026	Q4KWH8
KHASDASSISGSSNT	ZBTB24	516	O43167
SHRTGKDSEVSGSNS	ZNF445	381	P59923
AHSLDKTSHSSTTGL	WNK1	1526	Q9H4A3
SGTVAASKSVTAHLA	UGGT2	26	Q9NYU1
HSTAATSGLSLQSDT	ZNF831	1411	Q5JPB2
ESSSSLKTGRHSSGQ	GTF3C1	591	Q12789
ADHGQDSSSLSTSKS	TUT4	791	Q5TAX3
TGSLNHKASSDSAAS	ZNF106	411	Q9H2Y7
SEESATFHGSTTHTK	MUC12	526	Q9UKN1
STISGRSEESKASHS	MUC12	571	Q9UKN1
TTSGHSEKSTIFHSS	MUC12	1181	Q9UKN1
ASSTTSGHSEKSTIF	MUC12	2261	Q9UKN1
SSTTSGHSEKSTIFH	MUC12	2736	Q9UKN1
TTSGHSEKSTIFHSS	MUC12	3821	Q9UKN1
LSRAQKHSSGSSNTS	MXI1	51	P50539
ADTSAHSKAGSSSPE	MYPOP	166	Q86VE0